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Riassunto 
La conversione dell’anidride carbonica (CO2) in bicarbonato (HCO3-) e 
protoni (H+) è una reazione fisiologicamente rilevante in tutti gli organismi 
viventi. La reazione CO2 + H2O ⇋ HCO3- + H+ non catalizzata è lenta a pH 
fisiologici e quindi, nei sistemi biologici, è accelerata da catalizzatori 
enzimatici, noti con il nome di anidrasi carboniche (CA, EC 4.2.1.1). Le CA 
sono state trovate in quasi tutti i tessuti di mammiferi e tipi cellulari, e sono 
coinvolte nel trasporto della CO2 e in altri importanti processi fisiologici. 
Nella presente tesi è riportata la caratterizzazione biochimica di CA 
termostabili e termoattive identificate nel genoma di estremofili appartenenti al 
genere Sulfurihydrogenibium. Inoltre, è stato eseguito un ampio studio sui 
profilo di inibizione delle CA identificate nel genoma di organismi patogeni per 
l’uomo, quali Vibrio cholerae e Plasmodium falciparum. 
Le CA identificate nel genoma di S. yellowstonense e S. azorense sono 
risultate essere cataliticamente attive ad alte temperature e dopo 
immobilizzazione su supporti polimerici o paramagnetici. E’ stato dimostrato 
che tali CA sono ottimi candidati da impiegare nel processo di cattura della 
CO2. 
Le CA identificate nei patogeni suddetti sono state caratterizzate 
biochimicamente ed è stato condotto un ampio studio del loro profilo 
d’inibizione utilizzando gli inibitori classici delle CA, come sulfamidici e 
anioni. Tali studi sono fondamentali per ricerca di potenziali antibiotici con un 
nuovo meccanismo d'azione. Inoltre, la presente tesi ha contribuito alla scoperta 
di una nuova famiglia genica di CA, indicata con la lettera greca η; 
all'introduzione di una nuova tecnica, denominata protonografia, utile per 
l'identificazione dell’attività delle CA su gel di poliacrilamide; e all’analisi 
filogenetica delle CA di classe α, β e γ identificate nel genoma dei batteri 
Gram-positivi e Gram-negativi. 
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Abstract 
The conversion of carbon dioxide (CO2) to bicarbonate (HCO3
-) and 
protons (H+) is a physiologically relevant reaction in all life kingdoms. The 
uncatalyzed hydration-dehydration reaction CO2 + H2O ⇋ HCO3- + H+ is slow 
at physiological pH and thus, in biological systems, the reaction is accelerated 
by enzymatic catalysts, called carbonic anhydrases (CAs, EC 4.2.1.1). CA 
isozymes have been found in virtually all mammalian tissues and cell types, 
where they function in CO2 transport and other physiological processes.  
Here, are described the biochemical characterization of thermostable and 
thermoactive CAs from extremophiles belonging to the genus 
Sulfurihydrogenibium. Moreover, it has been carried out a wide study 
concerning the inhibition profiles of CAs identified in the genome of pathogens 
causing disease in humans, such as Vibrio cholerae and Plasmodium 
falciparum. 
CAs identified in the genome of S. yellowstonense and S. azorense were 
found to be active at high temperatures and preserved its activity after 
immobilization on paramagnetic or polymeric supports. It has been 
demonstrated that these CAs are good candidates in the CO2 capture process.  
CAs from the pathogens aforementioned were biochemically characterized 
and an extensive inhibition profile was carried out using the classical CAs 
inhibitors such as sulfonamides and anions. These studies have contributed to 
the search of antibiotics with a novel mechanism of action. Additionally, the 
present thesis has contributed to the discovery of the η-CA, a new genetic 
families of CAs; to the introduction of a new technique, named protonography, 
useful for the identification of CA activity on a polyacrylamide gel; and to the 
phylogenetic analysis of the α-, β- and γ-CAs identified in the genome of the 
Gram-positive and Gram-negative bacteria. 
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Chapter 1. Introduction 
1.1 Carbonic anhydrases 
Carbonic anhydrases (CAs, EC 4.2.1.1) are ubiquitous metalloenzymes 
present in all life kingdoms: Archaea, Bacteria and Eucarya. Formed by the 
convergent evolution of at least six families of genes (α, β, γ, δ, ζ and η). CAs 
have been identified for the first time in red blood cells of bovine (Meldrum 
N.U. & Roughton F.J. 1933). Later, they have been found in all mammalian 
tissues, but also in plants, algae and bacteria. CAs owe their ubiquity to the 
ability to catalyze a simple but physiologically relevant reaction for living being 
(Capasso C. & Supuran C.T. 2015), i.e. the reversible hydration of carbon 
dioxide with the formation of bicarbonate and protons according to the 
following formula: 
CO2+H2O ⇋ HCO3- + H+ 
The reaction of hydration of CO2 consists of four reactions: 
1) CO2(g) ⇋ CO2(aq)  reaction of dissolution in aqueous phase 
2) CO2(aq) + H2O ⇋ H2CO3 hydration reaction (carbonic acid production) 
3) H2CO3 ⇋ HCO3- + H+ ionization reaction (bicarbonate production) 
4) HCO3- ⇋ CO32- + H+ dissociation reaction (carbonate formation) 
 
In physiological conditions and in the absence of the catalyst, the reaction 2 
is the limiting step of the entire process and, the kcat assumes a value of 1.5 x 
10-1 s-1 (Edsall J.T. 1968). The carbonic anhydrase, able to convert a million 
molecules of CO2 per second, increases the value of the kcat from 10
-1 s-1 to 105 
s-1. CAs are among the fastest enzymes known. 
1.2 Physiological role of CAs 
CAs in mammals are involved in breathing and transport of carbon dioxide 
and bicarbonate in tissues and lungs, in the homeostasis of pH and CO2 in 
biosynthetic reactions such as gluconeogenesis, lipogenesis, ureagenesis, where 
the bicarbonate acts as a substrate for the reaction of carboxylation, bone 
resorption, calcification and tumorigenicity (Supuran C.T., et al. 2015). 
However, in microorganisms, in addition to the transport of carbon dioxide 
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bicarbonate and its supply of for biosynthetic reactions, carbonic anhydrases are 
involved in: a) carbon fixation for the photosynthetic process; b) metabolism of 
xenobiotics (degradation of the cyanate in E. coli); c) pH regulation; d) survival 
of the pathogen within the host organism; d) synthesis of purine and pyrimidine 
as in the protozoan Plasmodium falciparum (Supuran C.T. & Capasso C. 2014).  
In mammals, at the level of the peripheral tissue, due to the pressure 
gradient, the carbon dioxide, produced by the aerobic metabolism, leave the 
cells and enter the blood, dissolving in the plasma (reaction 1). From here, 
about 90% of the carbon dioxide enters the red blood cells and, thanks to the 
action of carbonic anhydrase reacts with water, forming carbonic acid (reaction 
2) which in turn dissociates into bicarbonate ion and hydrogen ion (reaction 3). 
Bicarbonate leaves the red blood cell by a protein antiporter. This transport 
process, defined exchange of chlorides, exchanges one HCO3
- ion with a Cl- 
ion. The exchange takes place in the ratio of 1: 1 by maintaining electrical 
neutrality and, consequently, the membrane potential of the cell is not changed. 
The ion HCO3
- is converted to carbonate and protons H+ (reaction 4), which are 
linked by hemoglobin, which acts as a buffer (Boron W.F. 2010). At the 
alveolar level, however, the CO2 concentration is lower than that in the 
peripheral tissues, while there is a higher concentration of bicarbonate that is 
pumped inside the red cell. Here, by the action of the reverse reaction catalyzed 
by the CAs, the bicarbonate is converted into carbonic acid, which will give 
water and carbon dioxide. The CO2 thus produced, is released into the blood 
and, passing by diffusion through the walls of the alveolus, is exhaled. The 
direction of the reaction, therefore, depends on the concentration of CO2: if this 
is low (as in the lungs), the acid is dissociated, with release of carbon dioxide; 
If this is high, dioxide binds water to form carbonates that are transported by 
the blood to the lungs (Boron W.F. 2010). 
1.3 CA classes 
 Until now were identified 6 distinct gene families of CAs (Supuran C.T. 
& Capasso C. 2014): 
• α-CA: invertebrates, fungi, protozoa, corals, algae, cytoplasm of green 
plants and some bacteria 
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• β-CA: mainly in bacteria, algae and plant chloroplasts mono and dicots, 
many fungi and archaea 
• γ-CA: mainly in archaea, some bacteria and plants 
• δ-CA: marine phytoplankton 
• ζ-CA: marine diatoms  
• η-CA: protozoa Plasmodium falciparum 
 
 
 
 
 
 
 
 
 
 Figure 1. Multialignment of the amino acid sequences of four human and 
bacterial CAs was realized with the ClustalW program, version 2.1. In red shows the 
amino acid residues of the catalytic triad, green residues "gate-keeper" and the blue 
"proton shuttle residual". It was used the numbering system hCA. 
The α-, β-, δ- and perhaps η-CAs use Zn(II) ions at the active site, the γ-
CAs are probably Fe(II) enzymes (but they are active also with bound Zn(II) or 
Co(II) ions), whereas the ζ-class CAs are cambialistic enzymes, active both 
with Cd(II) or Zn(II) bounded within the active site in order to perform the 
physiologic reaction catalysis. (Vullo D., et al. 2014; Del Prete S., et al. 2014; 
Capasso C. & Supuran C.T. Expert Opin. Ther. Pat., 23 2013).  
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In mammals, there are only α-CA, of which 16 isoforms were identified, 
marked with Roman numbers (Supuran C.T. et al., 2008; Supuran C.T., et al. 
2004; Scozzafava A., et al. 2000; Winum J.Y. et al. 2006; Saczewski F., et al. 
2006; De Simone G., et al. 2006). These isoenzymes can be distinguished 
according to the different tissue distribution, subcellular localization and 
catalytic activity (Supuran C.T. 2008). In particular, we divide the mammalian 
α-CA in: 
• cytosolic (isoenzymes I, II, III, IV, VIII) 
• mitochondrial (isoenzymes VA, VB) 
• membrane-bound (isoenzymes IV, IX, XII, XIV, XV) 
• secreted in saliva (isoenzyme VI) 
1.4 Catalytic mechanism  
In Figure 1 is reported the alignment of the α-CA amino acid sequences: 
four human isoforms (hCA I, hCA II, hCAVA and hCA VI) and two bacterial 
CAs represented by SspCA, identified in the genome of the thermophilic 
bacterium Sulfurihydrogenibium yellostonense and, VchCA present in the 
genome of the mesophilic bacterium Vibrio cholerae. In the alignment are 
highlighted the amino acid residues involved in the catalytic mechanism of the 
α-CAs, which consists of four steps. In the first step zinc ion, present in the 
catalytic site of the enzyme, is bound to the hydroxyl ion (Figure 2, Panel A). 
This configuration corresponds to the active form of the enzyme. The substrate 
CO2 is bound in a hydrophobic pocket near the Zn(II) ion, defined among 
others by residues Val121, Val143 and Leu198 (in the human isoform hCA II). 
Orientated in a favorable position for the nucleophilic attack of the enzyme, 
CO2 is transformed into bicarbonate. (Figure 2, Panel B). The bicarbonate ion is 
then displaced by a water molecule and released in solution (Figure 2, Panel C). 
In this way, the water molecule coordinated to the zinc, generates the acidic 
form of the enzyme, which is catalytically inactive (Figure 2, Panel D). The 
catalytically active form of the enzyme is regenerated through the reaction of 
transfer of a proton from the active site of the enzyme to the environment 
(Figure 2, Panel A). The speed of this transfer is highly dependent on the 
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residue His64 known as "proton shuttle residue" (Supuran C.T. 2008)(see 
Figure 2).  
 
 
 
  
 
 
 
Figure 2. Schematic representation of the catalytic mechanism of a α-CAs. 
In the catalytically very active isoenzymes, such as hCA II hCA IV, VII and 
hCA hCA IX, the transfer process of the proton from the enzyme to the 
environment is assisted by His64 positioned at the entrance of the active site 
and, by a cluster of histidine (His4, His3, His17, His15 and His10), which 
protrude from the edge of the active site of the enzyme on the surface, ensuring 
efficient removal of the proton by the enzyme (Figure 3). This explains why 
they are the most active known CAs (kcat/KM about 1.5 x 10
8 M-1 s-1) (Supuran 
C.T. 2008). In other CA, such as the hCA III, the catalytic efficiency is lower 
because the residue His64 was absent and in position 198, a phenylalanine 
replaces the residue of leucine causing a steric hindrance near the catalytic site 
(Chegwidden W.R., Carter N.D., Edwards Y.H. 2000). α-CAs are also able to 
catalyze the hydrolysis of esters/thioesters, (for example 4-nitrophenyl acetate 
(4-NpA) hydrolysis, as well as other hydrolytic reactions); while no esterase 
activity was detected so far for enzymes belonging to the other five CA genetic 
families. (Del Prete S, et al. 2014; Guzel O., et al. 2010).  
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Figure 3. Structure of the active site of hCAII. 
Are also known catalytically inactive isoforms of α-CAs, indicated as 
CARPs (Carbonic Anhydrase Related Proteins). The CARPs occur 
independently or as domains of other proteins in animals (both vertebrates and 
invertebrates) and viruses. Although these proteins show a high degree of 
homology with the other known CA isoforms (hCA I–VII, IX, and XII–XIV), 
they distinguish themselves from the catalytically active CAs by a salient 
feature: they lack one, two or all three zinc ligands from the enzyme active site, 
that is, His94, 96 and 119 (the hCA I numbering system). The phylogenetic 
analysis shows that these proteins are highly conserved across the species. The 
three CARPs in vertebrates are known as CARP VIII, X and XI. Most of these 
CARPs are predominantly expressed in central nervous system. Among the 
three vertebrate CA isoforms, CARP VIII is functionally associated with motor 
coordination in human, mouse and zebrafish and certain types of cancers in 
humans. Vertebrate expression studies show that CARP X is exclusively 
expressed in the brain. CARP XI is only found in tetrapods and is highly 
expressed in the central nervous system (CNS) of humans and mice and is also 
associated with several cancers. CARP VIII has been shown to coordinate the 
function of other proteins by protein-protein interaction, and viral CARPs 
participate in attachment to host cells, but the precise biological function of 
CARP X and XI is still unknown. (Aspatwar A., et al. 2014).  
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1.5 Characteristics of the CA classes 
1.5.1 α-CAs 
The most studied class of carbonic anhydrase, as well as that of which there 
are the largest number of three-dimensional structures, is the α-class. They 
contain the zinc ion (Zn2
+) in their active site coordinated by three histidine 
residues (His94, His96 and His119) and a water molecule/hydroxide ion (see 
Figure 4). Available α-CA structures, including most isoforms of human CA 
(hCA), reveal that the zinc ion is located in the pocket of the active site deep 15 
Å (Figure 4).  
 
 
 
 
 
 
Figure 4. 3D structure and a particular of the active site of the human isoform II (hCAII). 
Legend: Orange sphere is the zinc ion; His 94, His 96, His119 are the amino acid residues of the 
catalytic triad; Thr199 and Glu106 are gate-keeping residues.  
The water molecule bound to the zinc forms a hydrogen bond with the 
hydroxyl of Thr199, in turn linked to the carboxyl group of Glu106 (Supuran 
C.T., 2008). These interactions increase the nucleophilicity of the water 
molecule bound to the Zn(II) and orient the substrate (CO2) in a favorable 
position for nucleophilic attack. It is interesting to note that the above-
mentioned residues, are conserved in all human CAs with catalytic activity 
(Figure 1), with the exception of the human isoform hCAVA where the proton 
shuttle residues is missing. Up to date are available the crystallographic 
structures of α class CAs, such as hCA I, hCA II, hCA III, hCA IV, hCA V, 
hCA IX, hCA XII and hCA XIV (Alterio V., et al. 2012). Interesting, two 
human isoforms hCA IX and XII are associated with cancer and are involved in 
the pH regulation and progression of the tumor. The α-CA are normally found 
in monomeric form with a molecular weight of approximately 29 kDa, with the 
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exception of hCA VI, hCA IX and XII which occur as dimers (Boztas B., et al. 
2015; Dudutiene V., et al. 2014). The bacterial α-CAs, such as those identified 
in the genome of Sulfurihydrogenibium yellowstonense, S. azorense and 
Neisseria gonorrhoeae, are dimers formed by two identical active monomers. 
Among the various classes of CAs, the α-class are the most active. The 
reactions catalyzed by α-CA, as well as the physiological reaction of hydration 
of CO2 (Supuran C.T. 2008) are: hydration of cyanide to carbonic acid (1.1), or 
of cyanamide to urea (1.2 – 1.3), hydration of aldehydes to geminal diol (1.4), 
hydrolysis of carboxylic or sulphonic esters (1.5 – 1.6) in addition to other 
minor hydrolytic processes (1.7 – 1.9). Recently, it has been demonstrated that 
α-CA possess also the thioesterasic activity (1.10) (Tanc M., et al. 2015) (see 
list below).  
List of reactions catalyzed by α-CAs: 
(1.1) O=C=O+ H2O ⇋ HCO3-+ H+ 
(1.2) O=C=NH + H2O ⇋ H2NCOOH 
(1.3) HN=C=NH + H2O ⇋ H2NCONH2 
(1.4) RCHO + H2O ⇋ RCH(OH)2 
(1.5) RCOOAr + H2O ⇋  RCOOH + ArOH 
(1.6) RSO3Ar + H2O ⇋ RSO3H + ArOH 
(1.7) ArF + H2O ⇋ HF + ArOH  
(1.8) PhCH2OCOCl + H2O ⇋ PhCH2OH + CO2 + HCl 
(1.9) RSO2Cl + H2O ⇋ RSO3H + HCl  
(1.10) PhSO2NHCSSMe ⇋ C6H5SO2NH2 + CH4S +COS 
(Ar = 2,4-dinitrophenyl)  
(R = Me; Ph) 
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1.5.2 β-CAs 
Most of bacteria, archaea as Methanobacterium thermoautotrophicum, 
chloroplasts of algae and higher plants, contain CA belonging to the β-class 
(Smith K.S. & Ferry J.G. 2000; Smith K.S. & Ferry J.G. 1999; Badger M.R. & 
Price G.D. 1994; Nishimori I., et al. 2007). In β-CAs Zn(II) ion is coordinated 
by two Cys residues, a residue of His and the carboxyl group of a residue of 
Asp (Figure 5 and 6A). β-CAs identified in chloroplasts, have as fourth ligand a 
water molecule (Mitsuhashi et al. 2000; Smith K.S., et al. 1999; Cronk J.D., et 
al. 2001; Kimber M.S., et al. 2000) (Figure 6B). The residues of the catalytic 
triade are highly conserved (Figure 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Multi alignment of amino acid sequences of β-CAs belonging to plants, yeast, 
fungi and bacteria, made with the ClustalW program, version 2.1. It was used the numbering 
system of Pisum sativum. The ligands of Zn (II) are shown in red. Legend: FbiCA_plant, 
Flaveria bidentis, isoform I; VraCA_plant, Vigna radiata; PsaCA_plant, Pisum sativum; 
Can2_fungus; Cryptococcus neoformans; SceCA_yeast, Saccharomyces cerevisiae; 
CalCA_fungus, Candida albicans; HpyCA_bacterium, Helicobacter pylori. 
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Figure 6. Coordination of Zn (II) in the β-CAs. A: Porphyridium purpureum and 
Escherichia coli; B: Pisum sativum and Methanobacterium thermoautotrophicum. 
It has been demonstrated that at a pH of 7.5 or lower, the active site of 
carbonic anhydrase β is "locked", since the carboxyl group of an asparctic acid 
coordinates the zinc ion as a fourth ligand. At pH values higher than 8.3 the 
enzyme active site is converted in an open one, since the aspartate forms a salt 
bridge with residue Arg46 (numbering hpβCA) stored in all the carbonic 
anhydrase from β class (Nishimori I., et al., 2007). In this way, the molecule of 
water/hydroxide ion has the possibility to coordinate the metal ion to the 
completion of its tetrahedral geometry. As a result, the catalytic mechanism of 
β-CAs with the active site "open" is rather similar to the enzymes of α class. 
Respect to the α-class, β-CAs are oligomers formed by two or more identical 
subunits. Generally, β-CAs are dimers, tetramers and octamers. The monomeric 
subunit has a molecular weight of 25-30 kDa and the active form of the enzyme 
requires two subunits to reconstitute the catalytic site. Among the β-classes are 
available the crystal structures of the CA isolated from red alga Porphyridium 
purpureum, from chloroplasts of Pisum sativum, and prokaryotic CAs isolated 
from Escherichia coli and the archaebacterium Methanobacterium 
thermoautotrophicum (Cronk J.D., et al. 2001; Strop P., et al. 2001).  
1.5.3 γ-CAs 
The first γ-class carbonic anhydrase identified was isolated from the 
methanogenic archaebacterium Methanosarcina thermophila and is indicated 
by the acronym "Cam" (Smith K.S. & Ferry J.G. 2000; Kisker C., et al. 1996; 
Iverson T.M., et al., 2000; Innocenti A., et al. 2004; Alber B.E. & Ferry J.G. 
1994). Compared with the α-CA and β-CA Cam has a number of characteristics 
that differentiate it from these. In particular, the monomer Cam self-assembles 
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forming an active homo-trimer with an approximate molecular weight of 70 
kDa (Figure 7).  
 
 
 
 
 
 
 
 
Figure 7. Tridimensional structure of g-CA. The monomers are indicated by red, yellow 
and green colors.  
The single monomers of the γ-CAs, with molecular weight of about 20 
kDa, did not show catalytic activity. The active sites are localized at the 
interface between the monomers and the ion Zn(II) is coordinated by three 
histidine residues each coming from a monomer. γ-CA active site assumed a 
trigonal bi-pyramidal geometry in the Cam containing zinc ion, and an 
octahedral geometry in enzyme binding cobalt. The catalytic mechanism is 
similar to that proposed for the α-CA. At present, the mechanism zinc 
hydroxide, suggested for γ-CA is valid, but it is likely that in the active site of 
the enzyme may also be a balance between trigonal bi-pyramidal and 
tetrahedral metal ion species. The ligands in the active site of the enzyme, are in 
contact with the side chain of the residue Glu62, which suggests that this side 
chain can be protonated. In Cam, which has zinc uncomplexed, the side chains 
of residues Glu62 and Glu84 seem to share a proton and the residue Glu84 can 
be in multiple conformations. This suggests that the residue Glu84 performs a 
function similar to that of residue His64 in α-CA (Supuran C.T. 2008). 
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1.5.4 δ- e ζ-CAs 
Unlike δ-CAs, which are widely distributed throughout the marine 
phytoplankton, the ζ-CAs are present only in diatoms. Recently in the marine 
diatom Thalassiosira weissflogii have been identified two CA, TweCA (or 
TWCA1) and CDCA1, belonging respectively to classes δ and ζ (Alterio V., et 
al. 2012). TweCA is a 27 kDa protein, probably a monomer, which does not 
show significant sequence similarity with other carbonic anhydrases. It is an 
example of convergent evolution, even if the crystallographic studies show that 
the active site is similar to that of α-CA, with zinc ion coordinated by three 
histidine residues and one water molecule (Supuran C.T. 2008). The location of 
this enzyme in T. weissflogii and other diatoms it is not known, although recent 
studies suggest that TweCA has a cytoplasmic localization and catalyzes the 
reaction of dehydration of HCO3
- to CO2, increasing the concentration in the 
cytoplasm (Lee R.B.Y., et al. 2013).  
CDCA1 is a protein belonging to the family of the ζ-CA, is composed of 
three identical subunits named R1, R2, and R3 that form an active enzyme of 69 
kDa. CDCA1 contains in the catalytic site ion Cd(II), although it is able to 
operate even with the ion Zn(II) (Figure 8). The rapidity of the exchange 
between the metal ion Zn(II) ion and Cd(II) depends on the availability of the 
metal ions in the marine environment. In literature is reported the 
crystallographic structure of the three subunits that comprise it. (Xu Y., et al. 
2008).  
 
 
 
  
Figure 8. ζ-CA. Ion Cd (II) can be replaced by Zn (II) without losing the catalytic activity 
(numbering of the R1 subunit of the enzyme of T. weissflogii). 
In the subunit R2, the Cd(II) of the active site it is located in a pocket in the 
shape of funnel, coordinated by residues Cys263, His315, Cys325 and by a 
molecule of water. In the R1 subunit of CDCA1, the Cd(II) has a coordination 
identical to the R2 subunit (Figure 8). Since all three subunits have sequence 
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homology rather high, it is possible that the coordination geometry of the metal 
ion is similar also for the subunit R3. Since T. weissflogii grows in a marine 
habitat characterized by zinc salts and cadmium, it was hypothesized that the 
carbonic anhydrase CDCA1 containing cadmium, replace the enzyme TweCA 
in the mechanism of carbon concentration, when the concentration of marine 
zinc is very low. The mechanism of carbon concentration has developed in 
many species of phytoplankton to compensate for the low availability of CO2 
present in the water. In fact, carbonic anhydrases have the function of 
increasing the CO2 concentration in proximity of ribulose 1,5-bisphosphate 
carboxylase / oxygenase (RuBisCo), the primary enzyme involved in carbon 
fixation, by allowing the enzyme to work efficiently (Xu Y., et al. 2008). 
Therefore, the carbonic anhydrases are key enzymes regarding the acquisition 
of inorganic carbon for photosynthesis in the phytoplankton. 
1.5.5 η-CAs, the last discovered class. 
The causative agent of human malaria, Plasmodium falciparum, was one of 
the first protozoa to be investigated for the presence of CAs. The open reading 
frame of the malarial CA enzyme encodes a 600 amino acid polypeptide chain. 
In 2004, Krungkrai and coworkers cloned a truncated form of Plasmodium 
falciparum CA gene (GenBank: AAN35994.2) encoding for an active CA 
(named PfCA1) with a primary structure of 235 amino acid residues [77]. The 
metalloenzyme showed a good esterase activity with 4-nitrophenylacetate as a 
substrate. The authors observed that the highly conserved α-CA active site 
residues, responsible for binding of the substrate and for catalysis, were present 
also in PfCA1 and considered thus the Plasmodium enzyme belonging to the α-
CA class. (Figure 9).   
 
 
 
 
Figure 9. Multialignment of the amino acid sequence of the truncated form of the gene 
encoding for the PfCA1 with the amino acid sequences of the human isoforms (hCA I and II).  
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In the present thesis has been showed that PfCA1 is a new CA-class, 
denominated with the Greek letter η-CA (Capasso C. & Supuran C.T., 2015). In 
fact, the alignment of the three-dimensional structures related to PfCA1 and 
several members of the α-CAs, allowed us to reveal the unique characteristics 
of the η-CA (De Simone G., et al. 2015): the metal ion is coordinated by two 
histidine residues (His94, His96) and a residue of glutamine (Glu 119).  
1.6 Inhibitors 
There are two main classes of CA inhibitors (CAIs). The first class 
comprises the inorganic anions complexing metals, the second class includes 
organic ligands represented by the sulfonamides and related bioisosteres 
(sulfamates, sulfamides, hydroxamate and xanthates). Both classes of inhibitors 
work by coordinating the metal ion in the active site of the enzyme or through a 
replacement mechanism, forming tetrahedral adducts, or by an addition 
mechanism, generating trigonal-bi-pyramidal adducts (Figure 10) (Supuran 
C.T. 2008) according the following single reactions: 
A. E-Zn2+ - OH2 + I  E-Zn2+- OH2(I) (addition)  
trigonal-bi-piramidal adduct 
 
B. E-Zn2+ - OH + I  E-Zn2+ - I + H2O (substitution)  
tethraedral adduct 
 
Since the thirties of the last century, it was known that inorganic ions more 
effective in inhibiting the activity of CA were cyanate and thiocyanate ions 
(Meldrum N.U. & Roughton F.J. 1933). Generally, anion inhibitors bind to zinc 
for addition thereby generating the trigonal-bipyramidal adduct (Figure 10A). 
The inorganic inhibitors complexing metals find no application in therapy 
because of their poor selectivity as well as the resulting numerous side effects. 
Moreover, having a reduced size, it is very complicated, if not impossible, to 
perform an optimization of their structure (Supuran C.T. 2008).  
The sulfonamides derivatives even in this case their activity has long been 
known. In 1948, Krebs was the first to recognize its inhibitory action on CAs 
(Krebs HA, 1948) and, as of that date, the CAI entering treatment were dozens, 
even if, for some of these, the activities anti-CAs was not known. (Dogne J.M., 
et al.  2006; Knudsen J.F., et al. 2004; Supuran C.T. 2008). The primary 
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sulfonamides (R-SO2-NH2) are the classic inhibitors of CA and are used for the 
past half-century as diuretic and anti-glaucoma medications. Recently, they 
have also been found anticonvulsant, anti-obesity, anti-cancer, anti-infection 
and anti-panic properties, (Supuran C.T. et al. 2009; Winum J. et al. 2008; 
Domsic J.F., et al. 2008; Supuran C.T., et al. 2008; De Simone G. et al. 2008; 
Mincione F., et al.  2009; Krungkrai J. et al. 2008).  
 
 
 
 
Figure 10. CAs inhibition mechanisms. 
As discussed for the anions inhibitors, the mechanism of action of 
sulfonamides is based on the interaction of the inhibitor with the metal ion 
(Figure 10). In fact, the sulfonamide group, in contact with the acid 
environment of the catalytic site, loses a proton and forms a dative bond with 
the Zn (II) by substitution of the hydroxide ion (Figure 10 B). The inhibitor-
metal complex is stabilized by two hydrogen bonds between the sulfonamide 
group and the residue of Thr199 (Figure 11).  
 
 
 
 
 
 
Figure 11. Binding of sulphonamidic CAI. 
 
A B 
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Some of CAI having significant inhibitory activity, such as sulfonamide 
derivatives used in clinical (acetazolamide, methazolamide, ethoxzolamide, 
diclorofenamide, dorzolamide and brinzolamide) are able to form a second 
bond with the metal cofactor through one of the sulfonamide oxygen (Supuran 
C.T. 2008).  
The difficulties and problems founded in designing new CAs inhibitors as 
therapeutical agents are mainly due to the large number of human isoforms (16 
human CAs, 13 of which have catalytic activity), the widespread location of the 
CA in many tissues/organs as well the lack of selectivity of the currently 
available inhibitors. 
1.7 Activators 
Activators of the CAs (CAAs) unlike CAIs, who have been extensively 
studied and are used in the clinic for prevention and treatment of various 
diseases, still represent an almost entirely unexplored field. There is a multitude 
of compounds such as biogenic amines (histamine, serotonin, catecholamines), 
amino acids, oligopeptides and small proteins, that are capable of effectively 
activate many CA isoenzymes. Several CAA design studies, considered as lead 
molecules histamine or carnosine (Temperini C., et al. 2006; Nishimori I., et al. 
2007). Through the use of techniques, such us electron spectroscopy, X-ray 
crystallography and kinetics measurements that activators bind at the cavity of 
the active site, while CA inhibitors bind to metal core. CAAs participate in the 
displacement of the protons between the metal ion, bound to a water molecule, 
and the environment. This determines an increase of the hydroxylated forms of 
the metal, which corresponds to the catalytically active form of the enzyme 
(Clare B.W. & Supuran C.T. 1994). In the last few years, have been reported 
the crystal structures of the adducts formed by human isoforms hCA, hCAII 
and their activators (Temperini C., et al. 2007) in addition to those of histamine, 
dating to 1997 (Briganti F., et al. 1997). CAAs participate in a network of 
hydrogen bonds and hydrophobic interactions with specific amino acid residues 
or water molecules present in the active site. This explains their different power 
and ways of interaction with the various isoenzymes.  
  
17 
 
Chapter 2. Biotechnological and Biomedical 
application of CAs 
2.1 Carbon capture and storage (CCS) 
Has been repeatedly said that CAs are involved in a lot of physiological 
processes and relevant biochemical reactions, one of these is the carbon cycle 
and it is not surprising since the carbon is present in earth's atmosphere mainly 
as gas, the CO2 (about 1,500 billion tons of carbon are present in the biosphere) 
(Revelle R. & and Munk W. 1977). The carbon cycle is closely related to the 
flow of energy and productivity that crosses the biosphere. Photosynthesis and 
respiration are the two fundamental processes that govern this cycle and, are the 
main responsible for the major energy transfers, too. Photosynthesis is the first 
step of the carbon cycle. It allows that the carbon, present in the atmosphere as 
carbon dioxide, is fixed into organic compounds such as carbohydrates, fats, 
proteins and other biological molecules. The photosynthetic process is the 
anabolic phase of the carbon cycle and takes place out of the ground. In the soil, 
instead, it is realized the second step of the carbon cycle, i.e. the demolition of 
the organic substances produced by photosynthesis plant. In fact, organic 
debris, dead organisms containing carbon compounds, including sugars, 
cellulose, starch and others, are subject to the degradation, which corresponds 
to the catabolic phase of the carbon cycle. The catabolism of the carbon finally 
ends with the final processing into CO2, which in part is fixed in the ground in 
the form of calcium carbonate, in part in the water in form of carbonic acid and 
partly back into the air (Falkowski P., et al. 2000). Environmental CO2 is the 
primary source of carbon and, in recent years, has increased from about 280 
ppm to 390 ppm (Dlugokencky E. 2016). This increase was related to human 
activities during and after the industrial revolution, which began in 1850. In 
addition, from 1970 to 2004, CO2 emissions increased by an average of 9% a 
year. The amount of CO2 produced by human activities was higher than those 
assimilated from biomasses. Energy production, in fact, requires fossil fuels, 
which release about 24 billion tons of CO2 per year (Huesemann M.H., et al. 
2009; Falkowski P., et al. 2000). The production of CO2 is linked to the 
industrial development that must necessarily reduce its production and/or reuse. 
To stabilize CO2 in the atmosphere, a number of CO2 sequestration methods 
have been proposed (Reichle D., et al 1999). Most of them expect that the CO2 
captured from the flue gases is compressed, transported to the sequestration site 
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and injected within specific areas for long-term storage. This procedure 
determines an increase of the costs of the capture and storage processes (CCS). 
(Gentziz T., et al. 2000, Abadie L.M. & Chamorro J.M. 2008). In the last years, 
an industrial process very active is the biomimetic capture of CO2. This 
approach relies on use of the carbonic anhydrase, which is able to selectively 
bind the CO2 and transform it into carbonate ion (Borchert, M. & Saunders P. 
2008; Forsman C., et al 1988). However, the biomimetic approach is greatly 
limited by the harsh conditions required in these processes, i.e., high 
temperatures and high concentrations of organic ions and metals. (Bond G.M., 
et al. 2001; Fisher Z., et al 2012; Kanbar B. & Ozdemir, E. 2010). In order to 
capture CO2 have been developed different techniques, such as absorption into 
a liquid, adsorption on a solid, gas phase separation, and membrane systems 
(Yang H., et al. 2008), and among these the use of thermostable CAs has been 
described for chemical absorption (Wang M., et al. 2011).  
 
 
 
 
 
 
Figure 12. Schematic representation of a chemical absorption process. Red lines 
corresponds to absorber regeneration path.  
This process involves the reaction of CO2 with a chemical solvent to form 
an intermediate compound, which is then treated with heat, regenerating the 
original solvent and a CO2 stream. In a typical chemical absorption process 
(Figure 12), the flue gas containing CO2 enters from the bottom into a packed 
absorber column at low temperature (30–50 °C) and then contacts a CO2 
absorber; after absorption, the CO2-rich solvent is sent to a stripper operating at 
high temperatures (120–140 °C) to recover the absorber and CO2. After 
regeneration, the CO2-lean solvent is pumped back to the absorber for cyclic 
use, while the pure CO2 is compressed for the subsequent transportation and 
storage (Wang M., et al. 2011; Yu C.H., et al. 2012). The main energy cost 
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associated to this process is due to the heat required for the desorbption and the 
pumping of the absorbing solution around the system.  
The biomimetic approach represents an interesting strategy for CO2 
capture.  It, in fact, allows CO2 conversion to water-soluble ions, offering many 
advantages over other methods, for example its eco-compatibility and the 
possibility to use the enzyme for multiple cycles. Moreover, thermophilic 
enzymes are thermostable and thermoactive respect to the mesophilic 
counterpart, and their use is preferred in environments characterized by hard 
conditions, such as those of the carbon capture process (high temperature, high 
salinity, extreme pH). Additionally, there are some disadvantages using free 
enzyme in solution because the repeatable usage is limited, and generally is not 
possible to recover the enzyme from the reaction environment. Fortunately, 
these disadvantages can be eliminated immobilizing the enzyme on specific 
supports. 
 
 
 
 
 
 
 
 
 
Figure 13. Immobilization methods. 
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In literature have been described different immobilization techniques 
schematized in figure 13, such as adsorption (ionic interaction, hydrogen bonds, 
Van der Waal forces), covalent binding, crosslinking, copolymerization, 
encapsulation (membrane confinement).  
Table I. Attributes of immobilized enzymes. 
All of these processes have different advantages or disadvantage depending 
to the final application (Di Cosimo R., et al, 2013) (Table I) even if among all 
these methods, covalent immobilization generally ensures the highest strength 
of the bonding between support and enzyme. It, in fact, minimize the leakage 
issues, usually does not interfere with reagents/products mass transfer, and 
allows the highest enhancement of operational stability.  
Table II. Immobilization matrix classification. 
Classification of Supports  
Organic  
Natural polymers  
 Polysaccharides: cellulose, dextrans, 
agar, agarose, chitin, alginate 
 Proteins: collagen, albumin 
 Carbon 
Synthetic polymers  
 Polystyrene 
 Other polymers: polyacrylate 
polymethacrylates, polyacrylamide, 
polyamides, vinyl, and allyl-polymers 
Inorganic  
 Natural minerals: bentonite, silica 
 Processed materials: glass (nonporous 
and controlled pore), metals, controlled 
pore metal oxides 
Advantages Disadvantages 
Amenable to continuous and batch formats Loss of enzyme activity upon immobilization 
Reuse over multiple cycles possible Unfavorable alterations in kinetic properties 
Improved stability over soluble enzyme forms Cost of carrier and fixing agents 
Favorable alterations in pH and temperature 
optima 
Cost of immobilization process 
Sequester enzyme from product stream Mass transfer limitations 
Co-immobilization with other enzymes 
possible 
Subject to fouling 
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As shown in Table II, the matrixes or supports commonly used for 
immobilization of enzymes or whole cells are grouped in two major categories: 
1) Organic (natural polymers and synthetic polymers) and 2) Inorganic 
materials.  
The characteristics of the matrix are crucial in determining the performance 
of the enzyme and the system functionality. For example, an ideal support 
should have properties that include physical resistance to compression, 
hydrophilicity, inertness toward enzymes ease of derivatization, 
biocompatibility, resistance to microbial attack, and availability at low cost. 
(Trevan M., et al. 1980; Brodelius P. & Mosbach K. 1987; Bucholz K. & Klein 
J. 1987).  
2.2 Carbonic anhydrases from pathogens as druggable 
enzymes  
2.2.1 Pathogens 
The microorganisms that normally do not cause disease in humans, are in a 
state of commensalism or mutualism with the host (Roux O., et al. 2011; Joyce 
S.A., Watson R.J., Clarke D.J. 2006; Soto W., Punke E.B., Nishiguchi M.K. 
2012). This non-harmful condition occurs when the immune system works well, 
but the same organisms can cause infection when the latter fails. All 
microorganisms that cause diseases or illnesses to their host are defined as 
pathogens (Cardoso T., et al. 2012).  
Pathogens can be distinct into viruses, bacteria, fungi and protozoa. The 
pathogenicity of microorganisms is defined by the virulence, which is the 
ability of a pathogen to cause a damage more or less severe in the host (Webb 
S.A. & Kahler C.M. 2008; Grosso-Becera M.V., et al. 2015). Genetic 
characteristics, biochemical and structural properties of the pathogen influence 
the pathogen virulence, which allows the microorganism to cause disease 
through a set of actions on the host (Cardoso T., et al. 2012). These actions may 
be its ability to evade and/or fight the immune system, to assimilate nutrients 
from the host or to perceive environmental changes. All these abilities implicate 
the action of numerous enzymes. Enzymes considered as virulence factors are 
generally active against host components and contribute to virulence by 
damaging host tissues (Schaller M., et al. 2005; Alp S. 2006; Bostanci N. and 
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Belibasakis G.N. 2012).(Cox G.M., Mukherjee J., Cole G.T., et al. 2000; Cox 
G.M., McDade H.C., Chen S.C., et al. 2001).  
Cloning the genomes of many pathogenic microorganisms offered the 
possibility of exploring alternative pathways for inhibiting virulence factors or 
proteins essential for their life cycle. (Sainsbury P.D., et al. 2015). Using this 
approach, carbonic anhydrase has been identified in the genome of bacteria, 
fungi and protozoa, as a new class of enzymes related to microbial virulence 
(Capasso C. & Supuran C.T. 2013). 
2.2.2 Bacterial CAs 
Prokaryotes include several kinds of microorganisms, such as archaea, 
bacteria and cyanobacteria (Tibayrenc M. & Ayala F.J. 2012). It has been 
demonstrated that CAs are enzymes encoded by the genome of many 
pathogenic organisms. Recently, CAs started to be investigated in detail in 
several pathogenic bacteria, in the search for antibiotics with a novel 
mechanism of action, since it has been demonstrated that in many bacteria, CAs 
are essential for the life cycle of the organism. As reported in Table III, bacteria 
encode for enzymes belonging to the α-, β-, and γ-CA classes (Vullo D., et al. 
2014; Nishimori I., et al. 2014; Alafeefy A.M., et al. 2014; Vullo D., et al. 
2013). Thus, the α-CAs from Neisseria spp., Helicobacter pylori and Vibrio 
cholerae as well as the β-class enzymes from Escherichia coli, Helicobacter 
pylori, Mycobacterium tuberculosis, Brucella spp., Streptococcus pneumoniae, 
Salmonella enterica and Haemophilus influenzae have been cloned and 
characterized in detail in the last few years.  
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Table III. CAs from bacteria cloned and characterized so far, and their inhibition studies. 
Bacteria Class Acronym Inhibition studies 
   In vitro In vivo 
Neisseria gonorrhoeae α NgoCA Sulfonamides, anions Sulfonamides  
Neisseria sicca α NsiCA Sulfonamides Sulfonamides 
 
Helicobacter pylori 
 
α 
 
hpαCA 
 
Sulfonamides, anions 
 
Sulfonamides 
 
H. pylori 
 
β 
 
hpβCA 
 
Sulfonamides, anions 
 
Sulfonamides 
 
Escherichia coli 
 
β 
 
EcoCA 
 
- 
 
- 
 
Haemophilus influenzae 
 
β 
 
HICA 
 
Bicarbonate 
 
- 
 
Mycobacterium tuberculosis 
 
β 
β 
β 
 
mtCA 1 
mtCA 2 
mtCA 3 
 
Sulfonamides 
Sulfonamides 
Sulfonamides 
 
Sulfonamides, phenols 
Sulfonamides, phenols 
Sulfonamides, phenols 
 
Brucella suis 
 
 
β 
β 
 
bsCA 1 
bsCA 2 
 
Sulfonamides 
Sulfonamides 
 
Sulfonamides 
Sulfonamides 
 
Streptococcus pneumoniae 
 
β 
 
PCA 
 
Sulfonamides, anions 
 
Sulfonamides 
 
Salmonella enterica 
 
 
β 
β 
 
stCA 1 
stCA 2 
 
Sulfonamides, anions 
Sulfonamides, anions 
 
- 
- 
 
Vibrio cholerae 
 
α 
 
VchCA 
 
Sulfonamides, anions 
 
Sulfonamides 
 
Sulfurihydrogenibium 
yellostonense 
 
α 
 
SspCA 
 
Sulfonamides, anions 
 
- 
 
Sulfurihydrogenibium azorense 
 
α 
 
SazCA 
 
Sulfonamides, anions 
 
- 
 
Clostridium perfringens 
 
β 
 
CpeCA 
 
Sulfonamides, anions 
 
- 
 
Porphyromonas gingivalis 
 
γ 
 
PgiCA 
 
Sulfonamides, anions 
 
- 
 (─) to investigate     
Within the Bacteria domain, the enzymes from Neisseria gonorrhoeae, 
Neisseria sicca, H. pylori and V. cholerae belong to the α-class. The N. 
gonorrhoeae CA has a molecular mass of 28 kDa, being rather homologous to 
mammalian CAs and showing high CO2 hydratase activity (similar to the 
human isoforms hCA II) as well as esterase activity for the hydrolysis of p-
NpA. Instead, the H. pylori α-CA displayed an activity similar to that of the 
human isoform hCA I for the CO2 hydration reaction, being thus less efficient 
catalytically (see Table VI). (Cardoso T., et al. 2012; Cox G.M., et al. 2000; 
Cox G.M., et al. 2001; Bostanci N. & Belibasakis G.N. 2012; Alp S. 2006; 
Schaller M., et al. 2005;Tibayrenc M., & Ayala F.J. 2012;Roux O., et al. 2011; 
Joyce S.A., et al. 2006; Nishiguchi MK. 2012; Krungkrai S.R., et al. 2001; Sein 
K.K. & Aikawa M. 1998; Joseph P., et al. 2011; Supuran C.T. 2008). 
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The thesis has been focalized the attention on the carbonic anhydrases 
encoded by the genome of Vibrio cholerae. This gram-negative bacterium is the 
causative agent of cholera. The microorganism colonizes the upper small 
intestine where sodium bicarbonate is present at a high concentration. It has 
been demonstrated that sodium bicarbonate is an inducer of virulence gene 
expression in Vibrio (Cash R.A., et al. 1974). Since V. cholerae lacks of 
bicarbonate transporter proteins in its genome, it has been hypothesized that the 
pathogen utilizes the CAs system to accumulate bicarbonate into the cell to 
activate its virulence.  
2.2.3 Protozoan CAs 
Malaria, a mosquito-borne disease of humans and other animal species, is 
caused by parasitic protozoa species belonging to the genus Plasmodium. Six 
different Plasmodium species infect humans: Plasmodium falciparum, 
Plasmodium vivax, Plasmodium ovale, Plasmodium malariae and the zoonotic 
Plasmodium knowlesi. Malaria parasites follow a complex lifecycle that 
involves an intermediate host such as humans and the definitive host, the 
mosquito vector. Following injection of sporozoite stage parasites from an 
infected female Anophelene mosquito into a human host, Plasmodium parasites 
move to the liver and invade hepatocytes where they replicate to form 
merozoites that are ultimately released into the blood circulation. 
Few protozoan parasites have been investigated for the presence and 
druggability of CAs. The malaria-provoking organism Plasmodium falciparum 
was undoubtedly the first one. Protozoa utilize purines and pyrimidines for 
DNA/RNA synthesis during its exponential growth and replication. Plasmodia 
synthesize pyrimidines de novo from HCO3
-, adenosine-5’-triphosphate (ATP), 
glutamine (Gln), aspartate (Asp) and 5-phosphoribosyl-1-triphosphate (PRPP). 
HCO3
- is the substrate of the first enzyme involved in the Plasmodia pyrimidine 
pathway, which is generated from CO2 through the action of CA. Studies from 
Krungkrai’s and our laboratories showed that Plasmodium spp. encode for 
several -class CAs, and these enzymes have significant catalytic activity (as 
esterase with 4-nitrophenyl acetate as substrate) and are inhibited by primary 
sulfonamides, the main class of CAIs. The best investigated such enzyme has 
been denominated PfaCA1. Here, we showed thereafter that the situation is 
rather different: PfaCA1 is not an -CA but it belongs to the -class, being 
however sensitive to sulfonamide inhibitors.   
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Chapter 3. Materials and Method 
3.1 Identification of the CA genes in thermophilic and 
pathogenic bacteria 
To determine the presence of carbonic anhydrases have been used 
similarity searching programs, such as BLAST and FASTA. As query 
sequences were used the amino acid sequences of CAs belonging to α-, β- or γ-
class. The search showed that the genome of Sulfurihydrogenibium 
yellowstonense YO3AOP and Sulfurihydrogenibium azorense encoded for α- 
and γ –CAs. We focalized our attention on the most active class of CAs, the α-
class. The α-CAs S. yellowstonense and S. azorense were named SspCA and 
SazCA, respectively.  
The analysis performed on Vibrio cholerae genome identified three classes 
of carbonic anhydrase: the α-CA, indicated with the acronym VchCA; the β-
CA, named VchCAβ; and the γ-CA, called VchCAγ.  
The gene encoding for PfCA1 identified in the genome of the protozoan 
Plasmodium falciparum, were cloned into the pET-43.1a expression vector and 
kindly provided by Prof. Sally-Ann Poulsen Griffith University, Brisbane, 
Australia. 
3.2 Bacterial strains used for heterologous protein expression 
3.2.1 E. coli BL21(DE3) 
E. coli BL21 host strain is the most used in standard applications of 
recombinant expression. BL21-Gold (DE3) (Agilent) is a robust strain of E. 
coli, able to grow vigorously in minimal media (Chart et al., 2000). This strain 
presents the Hte phenotype, which increases the efficiency of transformation of 
the cells. In addition, the strain lacks of proteases OmpT and Leon, which can 
degrade the recombinant protein intact; and of endonuclease (endA), which can 
degrade the plasmid DNA isolated from mini preparations. The table IV shows 
other details of the cell genotype. The host strain lysogenized from the phage 
DE3 fragment, presents a copy of the bacteriophage T7 gene 1 integrated in the 
genome, which encodes the T7 RNA polymerase. Such gene is under the 
control of the promoter lacUV5 (derivative of the lac promoter) sensitive to the 
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adjustment by the cAMP-CRP complex and inducible by isopropyl-β-D-1-
tiogalattopiranoside (IPTG) (Studier & Moffat 1986). The T7 RNA polymerase 
drives the expression of the gene encoding for the recombinant protein. 
3.2.2 E. coli ArcticExpress (DE3) 
The strain of competent cells ArcticExpress (DE3) (Agilent) has the 
characteristics described above for the strain BL21-Gold (DE3) (Agilent). In 
addition, these cells are designed to deal with the problem of the insolubility of 
proteins, which may occur during the expression of the recombinant proteins. 
Arctic Express (DE3) cells, in fact, express proteins chaperone Cpn10 and 
Cpn60 of the psychrophilic bacterium Oleispira antarctica. These chaperonins 
have an amino acid identity with the chaperonins GroEL and GroES of E. coli 
by 74% and 54%, respectively, and show a good activity of protein folding at 
temperatures between 4 ° C and 20 ° C. These chaperonins, once expressed in 
cells ArcticExpress, optimize production of the heterologous protein at low 
temperatures and, presumably increase the amount of soluble and active 
recombinant protein produced. See table IV for more details on the genotype. 
3.2.3 E. coli DH5α 
Competent Cells Subcloning Efficiency ™ DH5α ™ (Life Technologies) 
are generally used to propagate plasmids and have good processing efficiency. 
This strain carries a mutation that inactivates the endonuclease I (endA1) that 
could degrade the plasmid DNA during the extraction, and a mutation which 
inactivates the endonuclease EcoK I, but not the methylase activity (hsdR17 
(RK, mk +). These cells lack the recombinase recA1 that is responsible for the 
recombination between the plasmid and the E. coli genome, making the plasmid 
more stable. They can also be used to blue/white screen for bacterial plates 
containing Bluo-gal or X-Gal. More details on the genotype are shown in table 
IV. 
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Table IV. Host strain genotype 
Host strain Genotype 
BL21-Gold (DE3) 
E. coli B F- ompT hsdS(rB- mB- ) dcm+ Tetr gal λ(DE3) 
endA The 
ArcticExpress (DE3) 
E. coli B F- ompT hsdS(rB- mB-) dcm+ Tetr gal λ(DE3) 
endA Hte [cpn10 cpn60 Gentr] 
Subcloning Efficiency™ DH5α™ 
F- Φ80lacZΔM15Δ(lacZYA-argF) U169 recA1 endA1 
hsdR17 (rk-, mk+) phoA supE44 thi-1 gyrA96 relA1 λ- 
 
3.3 Culture medium: LB (Luria-Bertani) 
The culture medium LB (Luria-Bertani), nutritionally rich and designed for 
the growth of pure cultures of recombinant strains, is prepared by dissolving 
20g of the prepared powder (LB BROTH, LENNOX-Laboratorios Conda) per 
liter of distilled water and sterilized by autoclaving at 121 ° C for 20 minutes. 
Heat-labile substances, such as antibiotics and IPTG, are added after 
sterilization and filtered with Millipore Millex-GP filter (0,22μm) during the 
preparation.  
3.4 Expression vector: pET15b (Novagen) 
The expression vector pET-15b (5708 bp) is constituted by an origin of 
replication and the gene for β-lactamase, which confers resistance to the 
antibiotic ampicillin, in addition to the viral T7 promoter, a multiple cloning 
site (MCS) for the enzymes restriction most common and a sequence that 
encodes a tag of histidines. The recombinant protein is expressed with the tag of 
histidines at the N-terminal (Figure 14), which allows the rapid purification of 
the recombinant protein by affinity chromatography using a specific resin 
loaded with metal ions. Furthermore, in the vector a cutting sequence 
recognized by the enzyme thrombin allows removal of the fusion tag. The 
expression of the gene cloned into the vector is controlled by the T7 promote 
and recognized specifically by the T7 RNA polymerase of E. coli. Its 
expression is induced by 'isopropyl-β-D-1-tiogalattopiranoside (IPTG). Once 
the polymerase has reached a sufficient expression level, it binds to the 
promoter and initiates transcription. 
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Figure 14. pET-15b Novagen cloning/expression region 
3.5 Cloning procedure 
3.5.1 Construct preparation 
The CA gene encoding for the recombinant protein have been designed 
using the Life Technologies software. All the genes encoding for a a-CAs were 
devoid of the signal peptide (first twenty amino acid residues of the peptide 
sequence) and fused at the N-terminal with a tag of histidines essential for the 
subsequent purification of the protein. These genes were synthetized and 
inserted by Life Technologies in the plasmid pMK-T, containing cleavage sites 
for the restriction enzymes NdeI and XhoI at the 5 'end and 3' of the genes, 
respectively. Subsequently, it was shipped to the laboratory. The 5 μg of 
plasmid aforementioned in lyophilized form were resuspended in 15μl RNase 
free water. The concentration was determined using the NanoDrop ™ 1000 
Spectrophotometer (Thermo Scientific). The DNA was stored at -20 ° C. 
3.5.2 Plasmid DNA amplification into E. coli DH5α cells 
The pMK-T cloning vector prepared as above was amplified using 
competent cells of E. coli DH5α. An aliquot of 50 µl of cells, stored at -80 ° C, 
was thawed on ice for 2-5 minutes and transformed with 100 ng of plasmid 
DNA. The cell suspension was mixed gently and placed on ice for 30 min. and 
then subjected to heat shock (42 ° C for 20 sec). After the addition of 950 µL of 
LB medium preheated, the mixture of transformation was incubated for 1 h at 
37 ° C on a horizontal shaker (CERTOMAT® BS-1), at a speed of 200 rpm. 
Then, a quantity ≥ 200 L of the mixture of transformation, were plated on solid 
medium (LB-Agar + kanamycin 50μg / ml) and the plates were incubated over-
night at 37 ° C. To obtain higher quantities and a better purity of the plasmid 
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DNA, it was set up a maxi preparation, for which a single bacterial colony was 
inoculated into 200 ml of LB containing ampicillin 100 mg/ml and made to 
grow at 37 ° C for 16 hours. The culture was then centrifuged at 5000xg for 5 
minutes and the pellet treated using The PerfectPrep EndoFree ™ Plasmid Maxi 
Kit (5 PRIME), following the procedures described in the manual. Briefly, the 
plasmid DNA was then adsorbed on a column of silica gel and separated from 
RNA, proteins and other cellular components. The final elution was achieved 
with ribonuclease free water. The DNA was stored at -20 ° C. 
3.5.3 Vector digestion 
The expression vector pET-15b was digested with the restriction enzymes 
NdeI and XhoI (Biolabs, New England). The digestion of the plasmid DNA was 
carried out for 60 minutes at 37 ° C using 50 U of enzyme NdeI, and 50 U of 
XhoI enzyme in a reaction mixture containing 3 micrograms of BSA in Tris-
HCl 6mM pH 7.5 containing 6 mM MgCl2, 50 mM NaCl and 1 mM DTT. The 
reaction was conducted in a final volume of 30 μl. After digestion, the 
linearized plasmid was treated with 0.1 U of bovine alkaline phosphatase and 
incubated at 37 ° C for 30 minutes. The alkaline phosphatase determines the 
dephosphorylation of the linearized plasmid to prevent it can reclose on itself. 
The sample was then loaded on 1% agarose gels in TAE buffer (Tris-acetate-
EDTA). The run was conducted using a horizontal electrophoresis apparatus for 
40 minutes at 90V. As molecular weight marker was used a mixture of DNA 
fragments of known size (1 Kb Plus DNA Ladder ™ Thermo Fisher Scientific). 
Agarose gel was prepared adding ethidium bromide to a final concentration of 
1μg/ml, to visualize the fragments of DNA by irradiation of the gel with 
ultraviolet light. The band corresponding to the linearized plasmid with NdeI 
and XhoI was excised from the gel and purified using Agarose GelExtract Mini 
Kit (5 Prime). The concentration of the purified plasmid was determined using 
the NanoDrop ™ 1000 Spectrophotometer (Thermo Scientific). Similarly, the 
pMK-T cloning vector, containing the genes coding for the CAs, was digested 
with the restriction enzymes NdeI and XhoI (Biolabs, New England). The band 
corresponding to the DNA encoding for CAs (SspCA or SazCA or VchCA or 
VchCAβ or VchCAγ) was excised from the gel and purified using Agarose 
GelExtract Mini Kit (5 PRIME). The concentration of the purified fragment 
was determined by NanoDrop ™ 1000 Spectrophotometer (Thermo Scientific).  
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3.5.4 Ligation Reaction 
50 ng of the fragment corresponding to the DNA encoding for CAs (SspCA 
or SazCA or VchCA or VchCAβ or VchCAγ) was ligated into the expression 
vector pET-15b (100 ng).  Constructs pET-15b / SspCA, pET-15b / SazCA, 
pET-15b / VchCA, pET-15b / VchCAβ and pET-15b / VchCAγ were 
generated. The ligation reaction was carried out at 16 °C for 16 hours in the 
presence of 400 U of T4 DNA ligase supplied in 10 mM Tris-HCl, pH 7.4, 0.1 
mM EDTA, 1 mM DTT, 200 mg / ml BSA and 50% glycerol, and 1X T4 DNA 
ligase buffer (50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM 
ATP, 25 mg / ml BSA) (New England BioLabs).  
Three μL of the ligation reaction were used to transform XL10-Gold 
Ultracompetent cells (Stratagene) with high efficiency of transformation. The 
transformation was performed by thermal shock, and the cells plated on 
medium containing as ampicillin 100 µg/ml (pET-15b contain the gene for 
ampicillin resistance) 
3.5.5 Clone identification 
Ten colonies grown on LB-agar plate with ampicillin 100 µg/ml were 
analyzed to verify the presence of the gene encoding the CA of interest in the 
construct prepared as described above. For this purpose, the plasmid DNA was 
extracted from the colonies selected using the “The PerfectPrep EndoFree 
Plasmid Maxi” kit (5 PRIME) based on the method of lysis with alkali as 
described by Sambrook et al. 1992. Each bacterial colony was inoculated in 200 
ml of LB containing ampicillin 100 µg/ml and grown at 37 °C overnight. The 
cultures were then centrifuged at 6000xg for 5 min at 4 ° C and the resulting 
pellet suspended in Tris-HCl 10 mM pH 8.3. The bacterial suspension was 
lysed under alkaline conditions and the lysate neutralized in a buffer with a high 
salt concentration. The plasmid DNA was then adsorbed on a column of silica 
gel and separated from RNA, proteins and other cellular components. The final 
elution was achieved by water ribonuclease free. To verify that the gene 
encoding for SspCA or SazCA or VchCA or VchCAβ or VchCAγ was correctly 
inserted, the purified plasmid DNA (100 ng/µL) was sequenced using the 
PRIMM service. 
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3.5.6 Construct amplification 
The amplification of the expression plasmid pET-15 b containing the gene 
encoding for the CA of interest (SspCA or SazCA or VchCA or VchCAβ or 
VchCAγ or PfCA1) was performed as described previously. 
3.6 Expression of heterologous proteins in E. coli cells 
3.6.1 Small-scale optimization 
To optimize the conditions for the expression of recombinant proteins, 
growth was performed in a small scale. After the addition of IPTG, the 
production of proteins of interest was monitored at different times of incubation 
(2h, 4h, 6h, and overnight). Moreover, it has also been used different 
concentrations of IPTG (0.1 mm, 0.5 mm, 1 mM). Aliquots of samples were 
analyzed by SDS-PAGE. 
3.6.2 Large scale expression  
For the heterologous expression of SspCA, SazCA, VchCA and VchCAβ it 
has been used E. coli BL21 (DE3) cells; while for the expression of VchCAγ 
and PfCA1 it has used ArcticExpress (DE3) cells. Competent expression cells 
were transformed using the thermal shock technique, which facilitates the 
passage of DNA through bacterial wall. Briefly, 50 µl of competent cells stored 
at -80 ° C, was thawed on ice for approximately 5 minutes. Then, the cells were 
incubated with for 10 minutes on ice in presence 1 µl of β-mercaptoethanol 
(1.42 M) and subsequently transformed with 100 ng of plasmid DNA. The cell 
suspension was mixed gently and placed on ice for 30 min. After the addition of 
950 µL of LB medium preheated, the mixture of transformation was incubated 
(1 h at 37 ° C on a horizontal shaker at a speed of 200 rpm). Then, a quantity ≥ 
200 L of the mixture of transformation, were plated on solid medium (LB-Agar 
+ Ampicillin, 100μg/ml) and the plates were incubated overnight at 37 ° C. 
Two-three bacterial colonies were inoculated into 100 ml of LB containing 
ampicillin and grow at 37 °C for 16 hours. The culture was diluted 10 times 
with fresh LB medium containing ampicillin and incubated at 37 °C and grown 
to the value of optical density at 600 nm of 0.6. Differently, ArcticExpress 
(DE3) cells were pre-incubated at 30 °C and once reached the 0.6 optical 
densities at 600 nm shifted to 20 °C. Then the cells transformed with the 
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construct pET-15b/SspCA, pET-15b/SazCA, pET-15b/VchCA and pET-
15b/VchCAβ were induced with 1 mM IPTG, while those transformed with the 
construct pET-15b/VchCAγ and pET-43.1a/PfCA1 were induced with IPTG 0.5 
mM. After half an hour from the induction with IPTG, ZnSO4 was added to the 
culture at a concentration of 0.5 mM. The metal ion was added because the zinc 
ion is essential for the catalytic activity and for the folding of the CA. 
Depending on the type of construct containing the CA of interest, after 4, 5, 6 or 
20 hours cells were harvested by centrifugation at 6000xg for 30 minutes in 
Sorvall RC 6 Plus ™ (Thermo Scientific). 
3.7 Purification of the recombinant CA  
3.7.1 Affinity chromatography 
Bacterial cells previously collected were suspended in 10 mM Tris-HCl pH 
8.3 (Vf = 50 ml), lysed by sonication using a Branson Digital Sonifier using 15 
cycles of 10sec with a 50 % of power. The sonicate was centrifuged at 10000xg 
for 45 minutes in Sorvall RC 6 Plus ™ (Thermo Scientific). All operations were 
performed at 4 °C. The supernatant was collected and purified by affinity 
chromatography on column HisTrapTM FF crude 1 ml (GE Healthcare Bio-
sciences) connected to an AKTA FPLC system. The column resin (Chelatin 
SepharoseTM High Performance) is agarose linked to iminodiacetic acid, able 
to chelate metal ions such as Ni2+ ions capable of coordinating the imidazole 
groups of the His-tag of our proteins (Figure 15). 
 
 
 
 
 
 
Figure 15. Schematic representation of His-Tag bounded to the beads of HisTrapTM FF 
column.  
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The column was prepared by passing approximately 20 ml of Milli-Q H2O 
(0.5 ml / min) and equilibrated with 10 column volumes of buffer A (20 mM 
imidazole, 20 mM phosphate buffer, 0.5 M NaCl pH 8 to a flow of 1 ml/min). 
Sample was loaded on the column at a constant flow of 1ml/min. Subsequently, 
washing was performed with 40 ml of buffer A. The protein, bound to the resin, 
was specifically eluted using an elution buffer (250 mM imidazole, 20 mM 
phosphate buffer, 0.5 M NaCl, pH 8) at a flow rate of 1 ml/min. Fraction were 
collected by recording the absorbance at 280 nm and dialyzed against 10 mM 
Tris-HCl, pH 8.3. Dialysis was performed at 4 ° C and using tubes with a cut-
off of 12000 Daltons, in order to remove the high concentration of imidazole 
used for the elution. The dialyzed protein was collected and analyzed by SDS-
PAGE. 
3.7.2 SDS-PAGE analysis of protein fractions 
The SDS-PAGE analysis of protein fractions obtained as described in the 
previous section was conducted according to the method described by Laemmli 
(1970). Each sample was dissolved in SDS Sample Buffer (62.5 mM Tris-HCl 
pH 6.8; 10% glycerol; 2% SDS; 10% β-mercaptoethanol; Bromophenol Blue 
0.05%) and heated for 7 minutes at 100 °C to denature proteins. After this 
treatment, samples were subjected to vertical electrophoresis by loading 20 µl 
of each sample on a polyacrylamide gel at 12.5%. The electrophoretic run was 
performed on Mini-PROTEAN® Tetra Vertical Electrophoresis Cell (BioRad) 
at a constant voltage of 150 V for about an hour, using the running buffer 1X 
Tris-Glycine SDS buffer, pH 8.3 (250 mM Tris base, 192 mM glycine and 1% 
SDS). A molecular weight marker ranging from 10-250 kDa (Precision Plus 
Protein ™ Dual Color Standards, BioRad) was used as standard. The protein 
bands were visualized by soaking the gel in the Staining Solution (0.025% 
Coomassie R-250; 50% methanol; 10% acetic acid; Milli-Q H2O to a volume of 
1 L) and subsequently in destaining Solution (10% methanol; acid 10% acetic; 
Milli-Q H2O to a volume of 1 L). To calculate the molecular mass of the 
protein in question has been used the program Compute pI/Mw (Gasteiger et 
al., 2005), accessible from the server of Molecular Biology ExPASy. 
3.7.3 Determination of protein concentration 
The protein concentration was determined by the Bradford assay (Bio-Rad 
Laboratories, Hercules, USA) that is based on the color variation of an acidic 
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solution of Coomassie Brilliant Blue G-250 (Bio-Rad mix, max of absorption at 
465 nm) in presence of protein. The color change results in an increase in 
absorbance from 465 nm to 595 nm, which is proportional to protein 
concentration. The calibration curve was constructed using known amounts of 
bovine serum albumin (BSA). For each sample (20 µL) were added 200 µL of 
the coloring solution Quick Start Bradford Dye Reagent 1x (BioRad) and water 
to reach the final volume of 1 ml. The blank was prepared with 20 µl of the 
buffer used for harvesting the cells. The samples thus prepared were incubated 
5 minutes at room temperature and read in a spectrophotometer at a wavelength 
of 595 nm. A three points calibration curve was prepared using known amounts 
of BSA. The sample unknown concentration was calculated using the first-
degree equation determined from the BSA calibration curve. 
3.8 Biochemical characterization 
3.8.1 Determination of the CA hydratase activity in solution 
The CAs activity assay is a modification of the procedure described by 
Chirica (Chirica L.C., et al. 1997) and is based on monitoring the change in pH 
due to the catalytic conversion of CO2 into bicarbonate. The indicator of the 
variation of pH is bromothymol blue (BTB) (Sigma-Aldrich). The assay was 
performed at 0 °C in a final volume of 1 ml. The CO2 saturated water was 
prepared by bubbling CO2 into 100 mL of distilled water for about 3 h. To test 
the activity of the enzyme, 100 µL of 250 mM Tris-HCl pH 8.3 containing BTB 
(to give a distinct and visible blue color), were placed in two tubes cooled in 
ice. Ten to 50 µl of enzyme solution (purified enzyme in 10 mM Tris-HCl pH 
8.3) were added to a test tube and, an equivalent amount of buffer was added to 
the second tube as a control. Immediately have been added 500 µl of water 
saturated with CO2 and 400 µl of Milli-Q water and simultaneously a stopwatch 
was started. The time taken for the color change of the solution from blue 
(alkaline pH) to yellow (acidic pH) was recorded (the range of color change is 
between pH 6.0 and pH 7.6). The production of H+ during the reaction of 
hydration of CO2 lowers the pH of the solution up to the transition point of the 
dye. The time required for the color change is inversely proportional to the 
quantity of CA present in the sample. Next, we have calculated the Wilbur-
Anderson units (WAU). One WAU of activity is defined as: (T0 - T) / T, where 
T0 (reaction not catalyzed) and T (reaction catalyzed) represent the time (in 
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seconds) necessary so that the pH falls from 8, 3 up to the transition point of the 
dye, in the control buffer, and in the sample in which is present enzyme 
respectively. 
3.8.2 α-CA esterase activity assay  
Differently from the other CA classes, the α-CAs are able to hydrolize the 
ester p-nitrophenyl acetate (p-NpA) in p-nitrophenolate and acetate. The 
activity of hydrolysis of p-NpA was determined using a modification of the 
method proposed by Armstrong (Armstrong J.M., et al. 1966). The reaction 
mixture was composed as follows: 300 µl of p-NpA 3mM, 700 µl 15mm Tris 
Sulfate buffer at pH 7.6 and 10μl of enzyme. The hydrolysis of p-NpA was 
monitored by the increase of p-nitrophenolate, which was measured at 348nm 
for 5 minutes using a spectrophotometer Varian's Cary 50 (Agilent 
Technologies). The catalyzed reactions were corrected for the non-enzymatic 
reaction. One unit of enzyme was defined as the amount of enzyme capable of 
producing an OD348nm = 0.03 in 5 minutes. 
3.8.3 Protonography 
It was set up a simple and inexpensive method, similar to zymography, 
which allowed the detection of CA activity on the polyacrylamide gel following 
the formation of H+ ions produced by hydratase of CAs. The technique was 
called "protonography” (De Luca V., et al. 2015). Briefly, samples were run on 
SDS-PAGE at a concentration of about 4 µg per well. The commercial bovine 
CA (bCA) was used as a control. SDS-Page was carried out as described in the 
section “SDS-PAGE analysis of protein fractions”, with the exception that the 
SDS sample buffer didn’t contain the β-mercaptoethanol and samples were not 
heated. Two SDS-PAGE gels were prepared: one was stained with Coomassie 
blue; the other was used to develop the protonogram. The last one was, in fact, 
treated with Triton X-100 at 2.5% and kept under stirring for one hour to 
remove the SDS. The gel was subjected to a washing step of 20 min with 100 
mM Tris-HCl, pH 8.3, containing 10% isopropanol. It was washed two times 
for 10 minutes. Finally, the gel was incubated for 30 minutes at 4 °C under 
stirring with 0.1% bromothymol blue (BTB) in 100 mM Tris-HCl pH 8.3. BTB 
is a pH indicator. To detect the hydratase activity, the gel was immersed in 
distilled water saturated with CO2 prepared by bubbling CO2 into 200 mL of 
distilled water for about 3 h. The localized decrease of the pH value, due to the 
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presence of the enzymatic activity of CAs, was detected through the formation 
of yellow band due to the change of color of the BTB from blue (alkaline pH) 
to yellow (acidic pH). 
3.8.4 Thermoactivity  
The temperature dependence activity of SspCA, SazCA and VchCA was 
determined using the p-NpA as substrate. The results were compared with that 
obtained for the bovine CA (bCA). In the assay were used 300 ng of protein. 
The reaction mixture was set up as described in the previous paragraph and the 
activity was measured at the temperatures ranging from 25 to 100 °C. 
3.8.5 Thermostability 
The CA thermal stability was evaluated through experiments of thermal 
inactivation. The recombinant CAs were incubated at 25, 40, 50, 60, 70, 80, 90 
and 100 ° C and aliquots were withdrawn at different times (30, 120 and 
180min). Enzyme concentration was 3µg/mL in a buffer composed of Tris-HCl 
10 mM, pH 8.3. The enzyme residual activity, expressed in percent of WAU, 
was measured at 0 °C using CO2 as a substrate. The results were compared with 
those obtained for a mesophilic enzyme (bCA) 
3.8.6 Determination of the kinetic and inhibition constants  
The kinetic and inhibition constants were obtained using the “stopped flow” 
apparatus. The apparatus (Applied Photophysics) is positioned in the laboratory 
direct by Prof. Claudiu Supuran, where have been collected all the kinetic 
results. The apparatus is made up of two main components: the mixing chamber 
and the observation chamber. As pH indicator it has been used phenol red 
(0.2mM), which operates at a maximum absorbance of 557 nm with HEPES 
buffer (acid 4-2-hydroxyethyl-1-piperazinyl-ethanesulfonic acid, an organic 
substance used to maintain the stable pH) 10 mM at pH 7.5 (for the α-CAs) or 
20 mM Tris (pH 8.3 for β- and γ- CA) and 0.1 M NaClO4 (to maintain ionic 
strength constant) at 20 ° C. The reaction was followed for a period of 10-100 
sec (the reaction is not catalyzed needs about 60-100 sec under the test 
conditions, while the reactions catalyzed need about 6-10 sec). For the 
determination of kinetic parameters and inhibition constants, the concentrations 
of CO2 are comprised between 1.7 and 17 mM. Stock solutions of inhibitor (10-
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50 mM) were prepared in deionized-distilled water and then, with the Assay 
Buffer were made dilutions to 0.01 µM. The inhibitor and the enzyme solutions 
were pre-incubated for 15 minutes at room temperature before assay, in order to 
allow the formation of the E-I complex (enzyme-inhibitor) or to the possible 
hydrolysis of the inhibitor, mediated by the active site. The kinetic parameters 
were determined using the diagram Lineweaver-Burk plot (or diagram of the 
double reciprocal), while the inhibition constants were obtained by the method 
of nonlinear least squares using PRISM 3 and represent the average of at least 
three different determinations. 
3.9 Immobilization 
3.9.1 Enzyme immobilization on polyurethane foam 
10 mg of SspCA were dissolved in 3mL of distilled water and added to 3 g 
of viscous prepolymer HYPOL2060 (a gift from Dow Chemical Co., Italy) in a 
50mL falcon tube. The solution was mixed vigorously for 30 s to achieve a 
homogeneous distribution of the enzyme within the prepolymer. The 
polymerization of the polyurethane is induced by the presence of water: the 
carbonyl group undergoes a nucleophilic attack by an OH- followed by a 
process of protonation, which causes release of CO2 and the conversion of an 
isocyanate group in an amino group (NH2). The latter group reacts instantly 
with the isocyanate group of a nearby molecule, giving rise to a cross-link 
between two polymer chains. In the presence of the enzyme, it is favored cross-
linkage between this and the pre-polymer given the availability of free amino 
groups on the surface of the enzyme. The CO2 gas generated by the process 
gives the foam cured a porous texture with spongy appearance. The solution 
started to polymerize as result of a CO2 release during the polymerization, 
which developed in 3–5 min. The polymer with the immobilized enzyme (PU-
SspCA) was left at room temperature for an additional 15 min before being 
used (Kanbar B. & Ozdemir E. 2010). After completion of the enzyme 
immobilization, PU-SspCA foam was chopped using an IKA Ultra-Turrax® 
T25 and assayed for CA activity using CO2 as substrate. The reaction was 
started by addition of the foam to the substrate-containing mixture under 
stirring. All the experiments were carried out in parallel with the mammalian 
enzyme. For studies on stability, foam slices containing the immobilized SspCA 
or bCA II were incubated at 100°C. The immobilized enzyme activity was 
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determined every 12 h over a total of 48 h. The assay was carried out using 
SspCA or bCA II and CO2 as substrate. 
3.9.2 Bioreactor 
The foam obtained as described in previous paragraph was placed inside a 
three-phase bioreactor (gas, liquid, solid) and was monitored the consumption 
of CO2 using a CO2 analyzer equipped with IR measuring cell (ABB URAS 
17). The bioreactor (length 30 cm, i.d. 4 cm), realized in Pyrex glass, was 
designed according to the three-phase trickle-bed configuration, and was able to 
operate in both concurrent down-flow and countercurrent flow. In order to 
separate both inlet and outlet currents of gas and liquid were inserted two 
porous septa (40-100 µm) and the lower septum working also as a packed bed 
support. In the countercurrent operation, the measuring pump allowed the bi-
distilled water to be fed from the top and the gas from the bottom (Migliardini 
F., et al. 2014).  
3.9.3 Preparation of Magnetic Particles 
Magnetic particles (MP) were prepared dissolving 8.1 g of FeCl3·6H2O in 
150 mL of distilled water, the resulting solution was kept under stirring at 70 °C 
in a conical flask. Subsequently, it has been added FeSO4·7H2O and 25% of 
NH3·H2O with shaking. After 1 min., were added 5 g of oleic acid dropwise and 
the reaction was conducted under stirring for 1 h. (Figure 16 A). The mixture 
was washed with ethanol three times and then, four times with distilled water. 
At the end of the washing procedure were added 0.016 mmol of H2SO4, 160 mL 
of distilled water and 1.6 g of KMnO4. The solution was stirred at 200 rpm for 4 
h. (Figure 16 B). The material produced was washed with distilled water and 
air-dried at room temperature (Figure 16 C). 
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Figure 16. Magnetic Particles (MP) preparation. 
3.9.4 Immobilization of CA on MP 
30 mg of carboxyl-functioned Fe3O4 magnetic particles were incubated 
with the 0.12 mg of free enzyme. The mixture was stirred at 120 rpm for 4 h in 
presence of 10 mL of Tris-HCl, pH 8.0.  
3.9.5 Activity measurement of immobilized CA on MP 
The activity of the immobilized CAs on the paramagnetic nanoparticles was 
determined using the method described in paragraph 2.8.2. 
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Chapter 4.  Biotechnological application results 
4.1 Biomimetic capture of CO2 
Recently, CAs began to be considered for biotechnological applications of 
enzymatic CO2 capture especially in relation to its increased emission in the 
atmosphere due to the anthropogenic activity (Huessemann M.H., et al. 2008; 
Greer T., et al. 2010; Fisher Z., et al. 2012). CAs, in fact, are very valid 
catalysts of the conversion of CO2 to bicarbonate, such enzymes may lead to the 
capture/sequestration of CO2 from combustion gases, and alleviate the global 
warming effects through a reduction of CO2 emissions in the atmosphere. CAs 
from mesophilic organism are subject to denaturation during the CO2 capture 
process characterized by extreme conditions, such as high temperature, high 
concentrations of salts, etc. For this reason, CAs present in the genome of 
extremophiles bacteria started to be investigated in detail ultimately. 
(Reysenbach, A.L., et al. 1992; Nakagawa S., et al. 2005; Aguiar P., et al. 
2004; Takai K., et al. 2003; Tu C., et al. 2001; Moya A., et al. 2008; Domsic 
J.F., et al. 2008; Supuran C.T.  2008; Xu Y., et al. 2008; Viparelli F., et al. 
2010; Alterio V., et al. 2012; Pastorekova S., et al. 2004). Generally, enzymes 
from thermophilic organisms, respect to the mesophilic counterpart, are 
thermostable and thermoactive representing good candidates in industrial 
processes characterized by extreme operating conditions. 
4.2 Protein identification 
Using as reference protein the amino acid sequence of the γ-CA from 
Methanosarcina thermophila, a moderate thermophilic methanogenic archaeon 
(Smith K.S. & Ferry J.G. 2000), and performing with “FASTA” program a 
search of sequences with significant similarity scores, we identified an α-CA 
encoded by the the genome of the extremophilic bacteria Sulfurihydrogenibium 
yellowstonense YO3AOP1 and Sulfurihydrogenibium azorense (Nakagawa S. 
2005; Aguiar P. 2004). The genus Sulfurihydrogenibium comprises 
chemolithotrophic bacteria able to survive in extremely harsh conditions of 
temperature (up to 110 °C) and in the presence of high concentrations of 
hydrogen sulfide (between 1 – 100 µ M). The two carbonic anhydrases were 
named respectively SspCA and SazCA. The recombinant enzymes, whose 
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nucleotide sequences were synthetized by Life Technologies, were 
heterologously expressed in Escherichia coli.  
 
 
 
 
 
 
 
 
 
 
Figure 17.  Multialignment of the amino acid sequences of α-CAs from different 
organisms performed with the program Clustal W, version 2.1. Legend: hCA I, Homo sapiens, 
isoform I; hCA II, Homo sapiens, isoform II; bCA II, Bos Taurus, isoform II; hpαCA, 
Helicobacter pylori J99 CA; NgCA, Neisseria gonorrhoeae enzyme; SsCA, Streptococcus 
salivarius PS4 CA; SspCA, Sulfurihydrogenibium sp. YO3AOP1; SazCA, 
Sulfurihydrogenibium azorense. Asterisk (∗) indicates identity at all aligned positions; symbol 
(:) relates to conserved substitutions; (.) indicate semi-conserved substitutions. In bold are 
indicated the residues involved in the enzyme CO2 hydratase. The zinc ligands (His94, 96 and 
119 in bold), the proton shuttle residue (His64, in bold) and the gatekeeper residues (Glu106 
and Thr199, in bold) are conserved in all these enzymes. The four loops absent in the bacterial 
enzymes are highlighted in grey. The numbering system used is that one from hCAI. 
4.3 Primary structure analysis 
The alignment of the SspCA and SazCA sequences, compared with that 
from other species (eukaryotic and prokaryotic) (Figure 17), indicated that the 
two bacterial polypeptide chains showed all the typical features of a α-CAs.   
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4.4 Cloning sequencing and production of expression vector 
In order to study the biochemical properties and chemical-physical 
properties of the CA identified, the two CAs, SspCA and SazCA were prepared 
using recombinant DNA techniques (see section “Materials and Methods”).  
4.5 Optimal expression conditions and production of the 
recombinant proteins 
Bacterial cells were transformed with the appropriate expression vectors, 
grown in rich medium and, after induction with IPTG and addition of the metal, 
samples were collected at various time points as described in "Materials and 
Methods". The induced cells synthesized the fusion protein, consisting of the 
HIS tag and the CA. The SDS-PAGE showed that the increased amount of 
SspCA and SspCA in the soluble fraction after sonication and centrifugation is 
obtained in about 5 hours after the induction with 1 mM IPTG. Defined the 
optimal conditions for growth, has been prepared the bacterial culture of 2.0 L 
by using the bacteria transformed with the construct of interest (pET-15b/ 
SspCA or pET-15b/SazCA). Cells were grown for 5 hours, resuspended in Tris-
HCl 10 mM pH 8.3 and disrupted by sonication. 
4.6 Purification of the recombinant proteins 
The recombinant proteins (SspCA and SazCA) were isolated and purified 
to homogeneity at room temperature from Escherichia coli BL21(DE3) cell 
extracts. CAs activities were recovered in the soluble fraction of cell extract 
obtained after sonication and centrifugation. The heterologously expressed 
SspCA and SazCA enzymes were purified by use of the affinity column (His-
select HF nickel affinity gel). The subunit molecular mass of about 26.4 kDa 
and 25.6kDa for SspCA and SazCA respectively, were calculated on the basis 
of the amino acid sequence translated from the gene. The molecular weight 
estimated by SDS−PAGE was 26.0 kDa (Figure 18). For both the proteins it 
was calculated purity of about 85% (Figure 18). 
43 
 
 
Figure 18. SDS-PAGE after affinity chromatography. Line 1: SazCA; Line 2: SspCA. 
4.7 Characterization 
4.7.1 Activity 
The recombinant proteins were assayed in solution using CO2 as a substrate 
using the procedure described by Chirica et al. (see “Materials and Methods”). 
Enzyme activity was expressed in Wilbur-Anderson units (WAU) (see 
experimental section). The table V showed specific activities of SspCA and 
SazCA compared with that obtained for the commercial bovine enzyme bCA 
(α-CA). Interesting to note as the SazCA specific activity is higher respect to 
those of the SspCA and bCA. 
α-CAs also catalyze the hydrolysis of esters, such as p-nitrophenyl acetate 
(p-NpA). Using this ester as substrate, we investigated the presence of esterase 
activity of the two bacterial enzymes comparing it with that of bCA enzymes. 
(Ferry J.G. 2010). SazCA showed a rather low specific activity towards p-NpA 
compared to SspCA and the mesophilic bovine α-CA (bCA). The SazCA 
esterase activity (62 U/mg protein) was 5 and 21 times lower than that of 
SspCA and bCA, ‘respectively’(Table V). 
  
Std                1                    2       
50 kDa 
37 kDa 
25 kDa 
20 kDa 
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Table V.  
  
Class 
Hydrase Specific 
activity 
(WAU/mg protein) 
Esterase Specific 
Activity 
(U/mg protein) 
SspCA α 6670 322 
SazCA α 50540 62 
bCA α 4845 1282 
 
4.7.2 Kinetic Constants 
The specific activities for SazCA, SspCA, hpαCA and hCA II were 
determined using CO2 as substrate, by a stopped-flow assay method (Khalifah 
R.G.J. 1971).  As reported in Table, the CO2 hydrase activity of SazCA was the 
highest among all CAs known to date, being 2.33 times higher than that of hCA 
II (considered the most active CA up until now). In table VI are also shown the 
inhibition constant (KI) obtained using acetazolamide the classic CAs inhibitor.  
Table VI. Comparison of the CO2 hydrase activities and inhibition constant with 
acetazolamide of SazCA, SspCA (from thermophilic bacteria), hpαCA (from Helicobacter 
pylori) and hCA II. All constants were determined to "stopped-flow" at 20 ° C and pH 7.5 in the 
laboratories headed by Prof. Claudiu Supuran of the University of Florence, Department of 
Chemistry. 
Enzyme kcat (s-1) KM (mM) kcat/KM (M−1 s−1) 
KI (nM) 
(acetazolamide) 
SazCA 4.40 × 106 12.5 3.5 × 108 0.90 
SspCA 9.35  × 105 8.4 1.1 × 108 4.5 
hCA II 1.40 × 106 9.3 1.5 × 108 12 
hpαCA 2.5 × 105 16.6 1.5 × 107 21 
 
All these enzymes were effectively inhibited by the sulfonamide 
acetazolamide, with inhibition constants in the range of 0.9 –21 nM. It may be 
observed that acetazolamide is an excellent, subnanomolar inhibitor of SazCA, 
being much more effective against this isoform than against hCA II (Table VI). 
Intriguingly, SazCA resulted more active than the hCAII considered the most 
active CA investigated until now.  
4.7.3 Thermoactivity and Thermostability 
We performed studies of thermoactivity and thermostability. The first 
measures the enzyme activity at a determined temperature; while the second 
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measures the enzyme activity after that it was incubated at a specified 
temperature for a determined time.  
The thermoactivity of SspCA and SazCA was determined at the 
temperatures of 25, 30, 40, 50, 60, 70, 80, 90 and 100 ° C using as substrate the 
p-NpA. The results were compared with those obtained for the bovine enzyme 
(bCA). The results showed that that SazCA and SspCA were active in the 
temperature range from 0 to 100 °C, unlike the mammalian enzymes which was 
denatured at temperatures higher than 60 °C (Figure 19 A). The optimal 
temperature for the bovine enzyme activity was found to be 60 °C and, as 
expected for thermophilic enzymes, SazCA and SspCA, showed an optimum of 
temperature at 80–90 °C. These enzymes were still active at 100 °C (Figure 19 
A). In Figure 19 B is reported the thermostabilities of SazCA, SspCA and bCA 
II at the temperatures indicated on the X-axis using CO2 as substrate and 
considering 30 min and 180 min as incubation time. The mesophilic enzyme 
(bCA II) was inactivated at temperature higher than 60 °C (Figure 19 B) for all 
the incubation times considered. Enzymes from extremophiles were active at 
the temperature up to 100 °C.  Interesting to note SazCA was more stable than 
the mesophilic enzyme and slightly less stable than SspCA. Our studies 
indicated that CAs from extremophiles were more stable at high temperature 
and retained their activity for a longer time (e.g., 180 min) when compared to 
the mammalian enzyme. 
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Figure 19. (A) Determination of optimal activity temperature of SazCA, SspCA and bCA. 
The enzyme activity was measured at the temperatures in the range from 25 to 100 ° C using p-
NpA as substrate. (B) Thermostability of SazCA, SspCA and bCA II. The enzymes were 
incubated for 30 and 180 min at the indicated temperatures on the X-axis and assayed using 
CO2 as substrate. Each point is the mean ± SEM of three independent determinations. 
The CAs investigated show a very high stability at various temperature, and 
survive to denaturation even after various cycles of heating at temperatures as 
high as 100 ° C. These two robust enzymes may have important applications in 
biotechnological processes, such us the CO2 capture due to their thermoactivity 
and (we stress again, SazCA is the most active CA known to date and SspCA 
the most stable) and thermostability (De Simone G. & Supuran C.T. 2012). It is 
important to note that there is massive industrial/biotechnological interest in 
using CAs as bio-catalysts for carbon sequestration and biofuel production 
(Fisher Z., et al. 2012).  
4.8 X-ray structure 
4.8.1 SspCA 
The determination of the SspCA crystallographic structure clarified the 
molecular basis of its exceptional thermostability (Di Fiore, A., et al. 2013). In 
particular, SspCA, like other α-CAs (Alterio V., et al. 2012), showed a fold 
characterized by a central ten-stranded β-sheet surrounded by several helices 
and additional β-strands (Figure 20 A). The active site is located in a deep 
conical cavity, which extends from the protein surface to the center of the 
47 
 
molecule, with the catalytic zinc ion positioned at the bottom of this cavity. The 
metal ion is tetrahedrally coordinated by three histidine residues (His89, His91 
and His108) and by the nitrogen atom of the inhibitor acetazolamide (AAZ), 
which was co-crystallized with the enzyme (Figure 20 B).  
 
 
 
 
 
 
 
 
Figure 20. (A) SspCA dimer structure (PDB code 4G7A) with one monomer shown in 
cyan and the other one in magenta; (B) enlarged view of SspCA active site showing the zinc ion 
coordination.).  
Interestingly, SspCA forms a dimer characterized by a large interface area 
and stabilized by several polar and hydrophobic interactions. This dimeric 
arrangement is a peculiar feature of all bacterial α-CAs so far structurally 
characterized (James P., et al. 2014, Huang S., et al. 1998, De Simone G., et al. 
2015).  
4.8.2 SazCA 
SazCA is the other thermostable α-CA isolated from the 
Sulfurihydrogenibium species and has been demonstrated to be the most 
catalytically active CA ever investigated so far (De Luca V., et al. 2013). Its 
CO2 hydration activity is 2.33 times higher than that of the highly active hCA 
II, with a kcat value of 4.40 × 10
6 s−1 and a kcat / KM value of 3.5 × 10
8 M−1· s−1 
(De Luca V., et al. 2013). Thermoactivity studies revealed that this enzyme 
presents an esterase activity in a temperature range of 0 to 100 °C, with an 
optimum working temperature at 80 °C. Thermal stability studies showed that 
SazCA is able to retain CO2 hydration activity after incubation at 100 °C for 3 
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h, even though it is less stable than SspCA (De Luca V., et al. 2013). The 
crystallographic structure of SazCA was recently determined (De Simone G., et 
al. 2015) (Figure 21).  
 
 
 
 
 
 
 
 
Figure 21. SazCA dimeric structure with one monomer shown in red and the other in blue. 
Zn2+ ion coordination and the inhibitor AZM are also shown. 
The analysis of this structure revealed the classical dimeric arrangement of 
bacterial α-CAs (James P., et al. 2015; Di Fiore A., et al. 2013; Huang S., et al. 
1998) and a substantial similarity with SspCA structure (Figure 22), in fact, the 
two enzymes have a sequence identity of 61.3%. (Di Fiore A., et al. 2013). 
However, a more detailed comparison allowed the identification of minor 
differences probably responsible of the difference in catalytic activity between 
SspCA and SazCA. Most of the residues of the active site are conserved in the 
two enzymes, however the substitution of the SspCA residues Glu2 and 
Gln207, located on the rim of the cavity, with His2 and His207 in SazCA, has 
been proposed to be responsible of the higher SazCA catalytic activity. These 
mutations might affect the pKa of His64 and consequently its ability to transfer 
the proton (De Simone G., et al. 2015). These results offer interesting prospects 
for the design of CA variants showing higher stability and catalytic activity than 
all other α-CAs known to date. 
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Figure 22. Superposition of the dimeric structure of SazCA (PDB code 4X5S, green) with 
those of SspCA (PDB code 4G7A, magenta and TaCA (PDB code 4C3T, blue). TaCA dimer 
was generated using PISA program (http://www.ebi.ac.uk) [Krissinel, E.; Henrick, K. Inference 
of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007, 372, 774–797.] on the 
crystallographic coordinates (PDB entry 4C3T). 
4.9 Immobilization 
4.9.1 Polyurethane  
From the results obtained, we have selected SspCA as a potential candidate 
to use in the CO2 capture process. We realized three-phase bioreactor (gas, 
liquid, solid) filled with the recombinant SspCA immobilized on polyurethane 
foam, a pre-polymer of polyethylene glycol. The polymerization of the 
polyurethane is induced by the presence of water: the carbonyl group undergoes 
a nucleophilic attack by an OH- followed by a process of protonation, which 
causes release of CO2 and the conversion of an isocyanate group in an amino 
group (NH2). The latter group reacts instantly with the isocyanate group of a 
nearby molecule, giving rise to a cross-link between two polymer chains. In the 
presence of the enzyme, it is favored cross-linkage between this and the pre-
polymer given the availability of free amino groups on the surface of the 
enzyme (Figure 23).  
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Figure 23. Polyurethane enzyme binding reaction 
The CO2 gas generated by the process gives the foam cured a porous 
texture with spongy appearance (Figure 24). The foam with the immobilized 
SspCA (PU-SspCA) was placed inside the bioreactor.   
 
 
 
 
 
Figure 24. Chopped polyurethane foam with immobilized enzyme 
The calculated specific activity of the PU-SspCA was similar to that of the 
free enzyme. Moreover, the dry polyurethane foam containing the immobilized 
SspCA or the free enzyme were stored at 25 ° C for several days. The free 
enzyme was stored in a buffer solution of 10mM Tris-HCl, pH 8.3. The PU-
SspCA specific activity was measured after 1, 6 and 30 days and compared with 
that of the free enzyme. PU-SspCA specific activity remained constant up to 
one month, while that of the free enzyme decreased slightly. These results are 
reported in table VII.  
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Table VII. Comparison of the hydratase activity for the immobilized and free enzyme 
incubated for several days at 25 ° C. 
 Hydratase Activity WAU/mg protein. 
Incubation time Pu-SspCA SspCA free 
1 day 1900 3250 
6 day 1934 3123 
30 day 1910 2756 
 
Once immobilized the enzyme adsorption capacity has been verified in 
laboratory. The experiments were realized using a laboratory plant based on a 
three-phase trickle-bed reactor formed by a solid phase, which corresponds to 
the immobilized catalyst, liquid and gas phases. This bioreactor was realized in 
collaboration with Dr. Migliardini and Dr. Corbo CNR. Istituto Motori (IM).  
(Migliardini F., et al. 2014). 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Schematic representation of a three-phase bioreactor 
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The gas phase was a mixture of N2/CO2 (20% by volume) injected from the 
bottom of the bioreactor (Figure 25), the aqueous phase was the distilled water 
inject from the top and the solid phase was the enzyme immobilized on 
polyurethane foam. The CO2 consumption was monitored using a CO2 analyzer. 
In Figure 26 are reported the results obtained using the lab-scale bioreactor 
described above. It has been shown that the immobilized PU-SspCA is capable 
of converting about 15% of CO2 from a gas mixture whose initial concentration 
was 20% (Figure 26). In the absence of catalyzer, (see yellow line in the graph 
of Figure 26) the spontaneous CO2 conversion was about 18%. These results 
confirm that the CA from extremophile is good candidate for use in the 
processes of CCS. 
 
 
 
 
 
 
 
Figure. 26 Conversion of CO2 in presence of 25 g of PU-SspCA (pink line) or 12 g PU-
SspCA (blue line) and PU without biocatalyst (yellow line).  
4.9.2 Paramagnetic particles 
It was decide to immobilize SspCA on a magnetic support for recovering 
the catalyzer from the bioreactor in a very easy and practical way, for example 
through the use of a magnet. For this purpose, SspCA was immobilized on 
paramagnetic particles (MP).  The immobilization yield on this new support 
prepared as described in “Materials and Methods” was about 95%. Interesting, 
the residual enzymatic activity of the immobilized enzyme was of 80% 
compared to that determined for the free enzyme in solution. This 
immobilization was better than done using PU as support. In fact, the enzyme 
immobilized on polyurethane, retained about 60% of its original activity. This 
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is due to the type of binding that is formed between the matrix and the 
immobilized enzyme. In fact, the immobilization PU-SspCA was covalent, 
while the immobilization on paramagnetic particles was ionic.  As described in 
literature, the covalent immobilization of an enzyme forces the molecule into a 
rigid conformation, which could alter the enzyme activity. The ionic binding 
(obtained using the paramagnetic particles) gives more degrees of freedom the 
immobilized molecule. Unfortunately, the ionic bond is more sensible to the 
stringent working industrial conditions, characterized for example by high 
temperatures and high alkaline concentrations. 
4.10 Inhibition studies 
We have investigated the inhibition profiles of SazCA and SspCA with 
some of the main representatives of the CA inhibitors (CAIs), such as inorganic 
anions, dithiocarbamate, sulfonamide and several small molecules 
incorporating zinc-binding moieties of the sulfonamide/dithiocarbamate type 
(Table VIII). Moreover, we also considered sulfur-containing compounds such 
as hydrogen sulfide, hydrogen sulfite, sulfate anions, halides and bicarbonate, 
which are present in the environment colonized by these extremophiles (Kubo 
K., et al. 2011;  Yang T., et al. 2011). 
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Table VIII. Inhibition of hCA II, SspCA, SazCA and hpαCA with several anions, 
sulfonamides and a dithiocarbamate. AAZ = acetazolamide, 5-acetamido-1,3,4-thiadiazole-2-
sulfonamide. 
Errors in the range of ±5% of the reported data from three different assays. 
Data shown in Table VIII reported that the halides were sub-millimolar 
inhibitors of SazCA (inhibition constants in the range of 0.87–0.98 mM with 
the four halide anions). SazCA has much higher affinity for these anions 
compared to SspCA or the human isoform hCA II, which were scarcely 
inhibited by these anions. The ‘extremo-α-CAs’ were strongly inhibited by the 
iodide ion respect to the mammalian hCA II and bacterial hpαCA. The 
structural modifications in the active site of the αCAs from extremophiles 
constitute the possible explanation for the difference in binding of the iodide 
ion. Bicarbonate was also a better SazCA and SspCA inhibitor compared to 
hCA II, whereas hydrogen sulfide inhibited better hCA II (KI of 40 μM) 
compared to the two bacterial enzymes (KI in the range of 380–580 μM). This 
may be an evolutionary adaptation of the bacterial enzymes from these 
extremophiles which survive in the presence of high concentrations of H2S, and 
the corresponding anions is thus less inhibitory for their catalytic activity 
compared to the human isoform hCA II.  
  KI (μM)   
Inhibitor hCA II SspCA  SazCA hpαCA 
F- > 300,000 417,000 980 4080 
Cl– 200,000 8300 850 2700 
Br– 63,000 49,000 940 2410 
I– 26,000 860 870 6050 
HCO3- 85,000 33,200 15,700 750 
HSO3- 89,000 21,100 950 990 
HS- 40 580 380 690 
SCN- 1600 710 580 4100 
SeCN- 86 70 490 730 
CS32- 8.8 60 39 380 
Et2NCS2— 3100 4.0 3.1 5.0 
SO42- > 300,000 820 10,000 820 
H2NSO3H 390 42 4.8 80 
AAZ 0.012 0.004 0.0009 0.021 
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Chapter 5. Biomedical application results 
5.1 Vibrio Cholerae 
Bacteria can increase cytosolic levels of bicarbonate through the 
transporters of the bicarbonate or through the action of enzymes, the carbonic 
anhydrase, which convert the CO2 to bicarbonate or metabolic than atmospheric 
entry into the cells by simple diffusion (Smith K.S. & Ferry J.G. 2000). The 
analysis of the genome of Vibrio cholerae through the use of the program 
FASTA (Pearson W.R., 1994) has evidenced the absence of nucleotide 
sequences of the bicarbonate transport system similar to those identified in S. 
elongates. It was hypothesized that V. cholerae uses the enzymatic system of 
the carbonic anhydrase to accumulate bicarbonate inside the cell. (Del Prete S., 
et al. 2014). From the inspection of the V. cholerae genome, carried out using 
the BLAST program, it was found that the pathogen encoded for three classes 
of carbonic anhydrase: the α-class CA, encoded by the gene cah 
(VC0395_0957), indicated by the acronym VchCA; the β-CA derived from the 
gene VC0395_A 0118, indicated by the acronym VchCAβ and a γ-CA encoded 
by the gene VC0395_A2463, indicated with the acronym VchCAγ. In 
prokaryotes, the existence of genes encoding CAs from at least three classes (-
, - and -class) suggests that these enzymes play an important role in the 
prokaryotic physiology. 
5.1.1 VchCA 
VchCA is a carbonic anhydrase belonging to α class and consists of 239 
amino acid residues. The figure 27 shows the alignment of VchCA with human 
(isoform hCA I and II) and bacterial α-CAs (hpyCA identified in the bacterium 
Helicobacter pylori; NgonCA identified in Neisseria gonorrhoeae).  
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Figure 27. Multialignment of amino acid sequences of the α-CAs encoded by the genome 
of Vibrio cholerae and other sources (see text for details) performed with the ClustalW 
program, version 2.1. Numbering system of hCAI was used. It has been reported the proton 
shuttle residue (dark green) and the gate-keeping residues (Asp, light green; Thr, blue).Legend: 
hCAI, Homo sapiens, isoform I; hCA II, Homo sapiens, isoform II; hpyCA, Helicobacter pylori 
J99; NgonCA, Neisseria gonorrhoeae; VchCA, Vibrio cholerae.  
VchCA shows an identity of about 30% with the two human isoforms and 
40% with bacterial CAs. Moreover, VchCA conserved all the characteristics 
common to other α-CAs, for example the amino acid residues of the catalytic triad, the 
proton shuttle and the gate-keeping residues. (Figure 27). 
  
 
 
 
 
 
 
Figure 28. Multialignment of the amino acid sequences of the β-CA belonging to plants 
and bacteria, obtained with the ClustalW program, version 2.1. It was used the numbering 
system of Pisum sativum. The ligands of Zn(II) are shown in red. Legend: FbiCA, Flaveria 
bidentis, isoform I; PsaCA, Pisum sativum; PgiCAb, Porphyromonas gingivalis; BsuCA, 
Brucella suis; VchCAβ, Vibrio cholerae. 
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5.1.2 VchCAβ 
VchCAβ is a β-CA formed by a polypeptide chain of 222 amino acid 
residues showing an identity of 40%, when compared with the β-CAs from 
Flaveria bidentis (FbiCA) and Pisum sativum (PsaCA) and, 30% when 
compared with the bacterial β-CAs from Porphyromonas gingivalis (PgiCA) 
and Brucella suis (BsuCA). The catalytic triad of a β-CAs is perfectly 
conserved in all these enzymes (Figure 28). Moreover, VchCAβ showed all the 
characteristics of a classical β-CA: the two cysteine residues and a histidine 
residue responsible for the catalytic mechanism (Figure 28). 
5.1.3 VchCAγ 
VchCAγ is a CA belonging to γ class with a polypeptide chain of 184 
amino acid residues. It shows an identity of 25-26% when compared with the 
two prototypes of the γ-CAs, CAM and CAMH, while presenting an identity of 
38% when compared with PgiCA (γ-CA of Porphyromonas gingivalis). In 
figure 29 is shown the multi alignment of VchCAγ with other bacterial γ-CAs 
identified in Porphyromonas gingivalis (PgiCA), Clostridium perfringes 
(CpeCA) and Methanosarcina termophila (CAMH and CAM). From figure 29 
it is possible to see that VchCAγ retains the three histidines (His81, 117 and 
122), responsible for the catalytic mechanism in all γ-CAs studied to date. 
 
 
 
 
 
 
Figure 29. Multialignment of amino acid sequences of the γ-CA belonging to bacteria, 
achieved with the ClustalW program, version 2.1. It was used the numbering system of CAMH. 
The ligands of Zn (II) are shown in red. Legend: PgiCA, Porphyromonas gingivalis; CpeCA, 
Clostridium perfringes; CAMH, Methanosarcina temophila; CAM, Methanosarcina temophila; 
VchCAγ, Vibrio cholerae. 
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5.2 Cloning sequencing and production of expression vector 
The three classes of CAs belonging to V. cholerae (VchCA, VchCAβ and 
VchCAγ) have been prepared using the DNA recombinant technology. The 
synthetic genes encoding for VchCA (657bp) or VchCAβ (669bp) or VchCAγ 
(552bp) were cloned into the expression vector pET-15b (see “Material and 
Methods”) 
5.3 Optimal growing condition and recombinant protein 
production 
Time course experiments were performed to optimize the protein 
expression. For this propose, bacterial cells were transformed with the 
appropriate expression vectors, grown in rich medium and, after induction with 
IPTG and metal addition, samples were collected at various time points as 
described in the experimental section. Compute pI/MW program calculated a 
theoretical molecular weight of 25 kDa for VchCA, of 29 kDa and 24 kDa for 
VchCAβ for VchCAγ. In this calculation was included also the His-Tag 
fragment. After the induction with IPTG, the SDS-PAGE showed that most of 
protein present in the soluble fraction was obtained after 5 hours for VchCA, 4 
hours for VchCAβ and 6 hours for VchCAγ.  
Once defined the optimum growth conditions a bacterial culture of 2.0 L 
has been prepared by using the bacteria transformed with the construct of 
interest (pET-15b/VchCA, pET-15b/VchCAβ, pET-15b/VchCAγ). Protein 
expression was performed as described in the experimental section. After 
having grown cells, the bacterial pellet was resuspended in Tris-HCl 10 mM pH 
8.3 and sonicated. 
5.4 Purification  
The bacterial extract obtained by sonication was purified by Nichel affinity 
chromatography as described in “Materials and Methods”. The fractions 
containing the protein of interest were dialyzed against 10 mM Tris-HCl pH 
8.3. The yield of the protein at the end of the purification process was 30 mg 
VchCA and VchCAβ 28 mg, while for VchCAγ it was recovered about 0.7 mg 
of total protein. The recombinant proteins were analyzed by SDS-PAGE. Vibrio 
CAs showed a single band of about 26 kDa (Figure 30). 
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Figure 30. SDS-PAGE after affinity chromatography. Std: standards; 1: VchCA; 2: 
VchCAβ; 3: VchCAγ.  
5.5 Biochemical characterization 
5.5.1 Activity 
The Vibrio CAs produced as described above were assayed in solution 
using CO2 as a substrate and following the procedure described by Chirica et al. 
Enzyme activity was expressed as Wilbur-Anderson units (WAU). Table IX 
shows specific activities of VchCA, VchCAβ and VchCAγ compared with that 
obtained for the bovine enzyme bCA (α-CA). The specific activity of VchCA is 
5.4 times higher than the commercial bovine enzyme (bCA), 16 times greater 
than that calculated for VchCAβ and 8 times that of VchCAγ. The results 
obtained demonstrate that the VchCA (α-CA) was the most active. Interestingly 
VchCAγ, is more active than VchCAβ (respectively the γ-class and β-class CAs 
founded in V. cholerae genome). Generally, γ-CA are reported to be less active 
than β-CAs  
  
Std         1            2           3     
50 kDa 
37 kDa 
25 kDa 
20 kDa 
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Table IX. Specific activity of the three classes of CAs identified in the genome of V. 
cholerae and of bovine α-CA. 
 Class Specific activity 
(WAU/mg protein) 
VchCA α 26232 
VchCAβ β 1600 
VchCAγ γ 3200 
bCA α 4845 
 
As described in literature α-class CAs, in addition to the hydration reaction 
of CO2, catalyze such as secondary reaction the reversible reaction of 
hydrolysis of esters. The esterase activity of VchCA, identified in the genome 
of V. cholerae, was determined using as substrate the p-NpA. VchCA presents a   
very low esterase activity (19 U/mg) compared with that of the commercial 
bCA (Table X).  
Table X. Esterase activity of VchCA and bCA. 
 
Class Specific activity 
(WAU/mg protein) 
VchCA α 19 
bCA α 1100 
 
5.5.2 Kinetic constants 
In Table XI are shown the rate constants (kcat, KM and kcat / KM) of the three classes 
of CA identified in the genome of V. cholerae and the inhibition constant (KI) using the 
inhibitor acetazolamide. These constants were compared with the kinetic parameters of 
other CA belonging to α-, β- and γ-classes identified in different organisms.  
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Table XI. Kinetic constants determination for the hydratase reaction catalyzed by CAs 
identified in the genome of V. cholerae. The results were compared with those obtained for CAs 
identified in other organisms. The inhibition constant was obtained for the classical sulfonamide 
inhibitor, acetazolamide. 
Class Enzyme Organism kcat (s
-1) 
KM 
(M) 
kcat/Km 
(M-1 s-1) 
KI (nM) 
(acetazolamide) 
α 
hCA I Mammal 2,00 × 105 4,0 × 
10-3 
5,0 × 107 250 
hCA II Mammal 1,40 × 106 9,3 × 
10-3 
1,5 × 108 12 
hpαCA Bacteria 2,5 × 105 16,6 × 
10-3 
1,5 × 107 21 
SazCA Bacteria 4,40  ×  106 12,5 × 
10-3 
3,5  ×  108 0,90 
SspCA Bacteria 9,35  ×  105 85 × 
10-3 
1,1  ×  108 4,5 
VchCA Bacteria 8,23 × 105 11,7 × 
10-3 
7,0 × 107 6,8 
β 
FbiCA 1 Plant 1,2 × 105 1,6 × 
10-3 
7,5 × 106 27 
BsuCA219 Bacteria 6,4 × 105 16,4 × 
10-3 
3,9 × 107 63 
BsuCA213 Bacteria 1,1 × 106 1,2 × 
10-3 
8,9 × 107 303 
PgiCAb Bacteria 2,8 × 105 18,6 × 
10-3 
1,5 × 107 214 
hpβCA Bacteria 7,1 × 105 14,7 × 
10-3 
4,8 × 107 40 
VchCAβ Bacteria 3,34 × 105 8,1× 
10-3 
4,1 × 107 451 
γ 
 
PgiCA Bacteria 4,1 × 105 7,5 × 
10-3 
5,4 × 107 324 
CAM Archea 6,1 × 104 7,0 × 
10-3 
8,7 × 105 63 
VchCAγ Bacteria 7,39 × 105 11,5 × 
10-3 
6,4 × 107 473 
 
VchCA showed a kcat of 8.23 × 105 s-1, a KM of 11.7 mM and a kcat/KM of 7.0 × 
107 M-1 s-1. VchCA was more active of the human isoform hCAI (kcat = 2.0 × 105 s-1) 
and hpαCA (kcat = 2,5 × 105s-1), it has an activity of an order of magnitude lower than 
hCA II and SazCA, an extremophilic CA from the genome of Sulfurihydrogenibium 
azorense. Furthermore, VchCA was inhibited by acetazolamide (KI = 6.8 nM) better 
than the hCA II and hpαCA.  
VchCAβ had a kcat of 3.34 × 105s-1 and a KM of 8.1 × 10-3s-1and a catalytic 
efficiency of 4.1 × 107 M-1 s-1. The enzyme showed a kcat similar to that of the enzyme 
identified in plant (FbiCA1) and its catalytic efficiency is very similar to that of other 
bacterial enzymes, but it was two orders of magnitude lower compared to the β-class 
enzyme identified in the bacterium Porphyromonas gingivalis (PgiCAβ). In addition, 
62 
 
acetazolamide was found to be a less effective inhibitor for VchCAβ than VchCA, 
showing an inhibition constant of 451 nM (Table XI). 
VchCAγ showed a kcat of 7.39 × 105s-1, an order of magnitude higher than that of 
γ-CA (CAM) identified in the thermophilic Archeon Metanosarcina thermophila and, 
slightly higher than the kcat of the bacterial γ-CA PgiCA. Interestingly, VchCAγ 
resulted more active than VchCAβ, while the acetazolamide shows an inhibition 
constant of 473 nM. 
5.5.3 Thermoactivity and Thermostability 
Thermoactivity was only determined for VchCA because this is the unique 
class of CA (α-CA) that possesses an esterase activity. The results were 
compared with those obtained for the bovine enzyme, bCA. In Figure 31 is 
shown that VchCA activity is shifted of 10 degrees respect to that of the 
mammalian enzyme. bCA, in fact, showed a maximum peak of enzyme activity 
at 60 ° C, while for VchCA this peak was at 70 ° C (Figure 31).  
 
 
 
 
 
 
Figure 31. Comparison of the thermoactivity of VchCA and bCA. The enzyme activity 
was measured at the indicated temperatures on the x-axis using the p-NpA as a substrate. Each 
point is the mean ± SEM of three independent determinations. 
This variation may be due to the fact that the enzyme of Vibrio cholerae is 
characterized by an amino acid sequence shorter than bCA, which probably 
confers stability to the bacterial enzyme. 
Thermostability of VchCA, VchCAβ, VchCAγ and bCA were investigated 
incubating each enzyme at 30, 40, 50, 60, 70, 80 and 90 ° C. After 30 and 120 
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minutes of incubation, an aliquot of each enzyme was taken and assayed using 
CO2 as a substrate. Figure 32 showed that after 30 minutes of incubation the 
activity of the bovine enzyme (bCA) decreases faster than that of VchCA. In 
fact, at 80 °C the residual activity for VchCA is 40%, while for bCA is 0. 
VchCAγ and VchCAβ have a behavior very similar to the bovine enzyme 
(Figure 32). After 120 minutes of incubation, the bCA and VchCAβ are inactive 
at temperatures higher than 60 ° C, VchCAγ is inactivated at 70 °C, while 
VchCA is completely inactive at 80 °C. These results demonstrated that VchCA 
is more stable respect to the β and γ-CAs identified in the genome of Vibrio 
cholerae. 
 
 
 
 
 
 
 
Figure 32. Thermostability of VchCA, VchCAβ, VchCAγ and bCA. The enzymes were 
incubated for 30 to 120 minutes at the indicated temperatures on the x-axis and assayed using 
CO2 as a substrate. Each point is the mean ± SEM of three independent determinations. 
5.5.4 Protonography 
The activity of proteolytic enzymes, capable of refold and acquire the 
proteolytic activity after treatment with SDS, can be determined by SDS-PAGE 
after the removal of the detergent. Such a technique is known with the name of 
zymography. It has developed a technique to identify the activity of CA 
hydratase on SDS-PAGE (see Materials and Methods), we named this 
technique protonography, because during the CO2 hydratase reaction are 
produced protons, which are then responsible of the change of color that 
appears on the gel, in correspondence of the CA (see Material and Methods).  
In figure 33 are reported the protonograms obtained using bovine bCA (α-
CA class) and the recombinant CAs (α, β and γ) from V. cholerae. 
Protonograms of VchCA, VchCAβ and VchCAγ showed the different behavior 
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that the three bacterial CAs assumed during the SDS-PAGE. It is known that 
mammal α-CAs are monomeric and the protonogram of bCA showed a single 
band of activity corresponding to a monomer of 30 kDa (Figure 33 A). The 
bacterial α-CAs are generally dimeric enzymes and the protonogram showed 
three bands of activity: a monomer (25 kDa), a dimer (50 kDa) and a tetramer 
(100 kDa) (Figure 33 A). Therefore, unlike bCA, VchCA is present in three 
different oligomeric states. The protonogram of VchCAβ (Figure 33 B) showed 
two bands of activity: a band corresponding to the monomeric form (29 kDa) 
and one at the dimeric form (58 kDa). The protonogram of VchCAγ showed a 
band of activity in correspondence of the monomer (24 kDa) and the trimer (69 
kDa) (Figure 33C). The yellow bands found in correspondence of the inactive 
monomeric form of VchCAβ or VchCAγ, is due to the fact that at the end of the 
electrophoretic run, the SDS is removed from the gel. This procedure may lead 
to the rearrangement of β- or γ-CA monomers in the gel and the final result is 
the reconstitution of the active dimeric (β -CA) or trimeric forms (γ -CA). 
Protonography allowed us to distinguish not only the active enzyme, but also 
oligomeric states of the CA.  
 
 
 
 
 
 
 
Figure 33. A: protonogram and SDS-PAGE stained with Coomassie compared. Both Gels 
were run in non-reducing denaturing conditions and loaded with 4 micrograms of bCA and 
VchCA. The appearance of the band occurred after 5 seconds of incubation in CO2 saturated 
water. B: protonogram of VchCAβ with a molecular weight marker (Coomassie gel not shown). 
The band appeared after 40 seconds of incubation in CO2 saturated water. C: protonogram of 
VchCAγ with a molecular weight marker (Coomassie gel not shown). The band appeared after 
25 seconds of incubation in CO2 saturated water. 
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5.6 Inibition 
5.6.1 Sulfonamides and the bioisosteres 
In collaboration with Prof. C. Supuran, University of Florence, a large 
number of sulfonamides and sulfamates were tested to evaluate their 
effectiveness on the inhibition of V. cholerae CA.  
Simple aromatic and heteroaromatic sulfonamides of types 1-24 were 
among them, as well as derivatives AAZ-IND, which are clinically used drugs 
or agents in clinical development (Figure 34). Acetazolamide AAZ, 
methazolamide MZA, ethoxzolamide EZA and dichlorophenamide DCP, are 
the classical, systemically acting CAIs. Dorzolamide DZA and brinzolamide 
BRZ are topically-acting antiglaucoma agents, benzolamide BZA is an orphan 
drug belonging to this class of pharmacological agents, whereas topiramate 
TPM and zonisamide ZNS are widely used antiepileptic drugs. Sulpiride SLP 
and indisulam IND were recently shown by this group to belong to this class of 
pharmacological agents. Sulfonamides 1-24 and the clinically used agents 
investigated in this study were either commercially available, or were prepared 
as reported earlier by our group (Figure 34). 
The study of inhibition profiles has the aim to identify the existence of 
selective inhibitors for the CA identified in the genome of V. cholerae. Some of 
these compounds are excellent inhibitors of bacterial enzymes (Table XIII). 
These results will be of great assistance for the realization of new inhibitors 
characterized by a high selectivity towards the bacterial CAs. 
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Figure 34. Sulfonamides and bioisosteres inhibitors structures.  
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Table XII.  Sulfonamides and bioisosteres inhibition constants for the human α-CA 
isoforma I and II, the α-CA of H. pylori (hpαCA) and the three classes of CA identified in the 
genome of V. cholerae, obtained with the technique of "stopped flow" at 20 ° C and pH 7.5. 
KIa (nM) 
Inhibitor hCA I hCA II hpαCA VchCA VchβCA VchγCA 
1 45400 295 426 440 463 672 
2 25000 240 454 471 447 95,3 
3 28000 300 316450 125 785 93,6 
4 78500 320 873 219 >10000 76,3 
5 25000 170 1150 447 >10000 80,6 
6 21000 160 1230 402 >10000 69,0 
7 8300 60 378 199 >10000 73,6 
8 9800 110 452 139 9120 73,6 
9 6500 40 510 133 >10000 95,3 
10 6000 70 412 99,1 >10000 544 
11 5800 63 49 62,9 879 87,1 
12 8400 75 323 45,3 4450 563 
13 8600 60 549 23,5 68,1 66,2 
14 9300 19 268 12,1 82,3 69,9 
15 6 2 131 4,2 349 88,5 
16 164 46 114 42,7 304 556 
17 185 50 84 30,3 3530 6223 
18 109 33 207 59,8 515 5100 
19 95 30 105 4,7 2218 4153 
20 690 12 876 0,59 859 5570 
21 55 80 1134 54,5 4430 764 
22 21000 125 1052 56,7 757 902 
23 23000 133 541 71,5 817 273 
24 24000 125 21 52,1 361 73,3 
AAZ 250 12 225 6,8 4512 473 
MZA 50 14 193 3,6 6260 494 
EZA 25 8 378 0,69 6450 85,1 
DCP 1200 38 4360 37,1 2352 1230 
DZA 50000 9 210 6,3 4728 87,3 
BRZ 45000 3 315 2,5 845 93,0 
BZA 15 9 172 4,2 846 77,6 
TPM 250 10 231 >1000 874 68,8 
ZNS 56 35 204 982 8570 725 
SLP 1200 40 413 >1000 6245 77,9 
IND 31 15 nt 8,1 7700 91,3 
VLX 54000 43 nt 89,7 8200 817 
CLX 50000 21 nt >1000 4165 834 
SLT 374 9 nt 88,4 455 464 
SAC 18540 5959 nt >1000 275 550 
HCT 328 290 nt 79,5 87,0 500 
a error in the range of 5-10% for the reported values; nt = not tested 
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Table XII showed inhibition data for this panel of sulfonamides (and one 
sulfamate, TPM) against the human α-CAs (isoforms hCAI and hCAII) and the 
recombinant α, β and γ CAs from Vibrio cholera. The following should be 
noted regarding a comparison of V. cholerae enzymes inhibition with the 
compounds investigated in this study: (i) Topiramate TPM, a sulfamate, 
sulpiride SLP, a primary sulfonamide, as well as saccharin SAC, an 
acylsulfonamide, were ineffective VchCA inhibitors (KIs>1000 nM). Moreover, 
SAC was a bad inhibitor for VchCAβ and VchCAγ, while TPM and SLP were 
effective inhibitors of VchCAγ. These compounds (except saccharin) generally 
act as good inhibitors of other bacterial or mammalian α-CAs. Zonisamide, 
ZNS, an aliphatic primary sulfonamide was also a very weak inhibitor for the 
bacterial enzymes but effective towards the human enzymes (KIs ≥725 nM); (ii) 
A large number of simple aromatic sulfonamides, such as derivatives 1-9, 
showed moderate VchCA and VchCAγ inhibitory properties, with inhibition 
constants in the range of 125 – 672 nM (Table XIII). It may be observed that all 
these derivatives are benzenesulfonamides with one or two simple substituents 
in ortho-, para- or the 3,4-positions of the aromatic ring with respect to the 
sulfamoyl zinc-binding moiety. Most of these CAIs were ineffective towards 
VchCAβ with KIs ≥ 9120 nM; (iii) Most of the sulfonamides investigated here 
showed a potent inhibitory effect against VchCA, VchCAβ and VchCAγ with 
inhibition constants in the range of 23.5 – 88.5 nM. These derivatives include 
compounds 13-15. It is interesting to note that compounds 10-13, 16-18, 21-24, 
DCP, VLX, SLT and HCT showed a potent inhibitory effect against VchCA. 
Some of them are effective towards VchCAβ or VchCAγ but never effective for 
all the three classes identified in the genome of V. cholerae (Table XII); (iv) 
Several very potent VchCA inhibitors were detected, such as compounds 14, 
15, 19, 20, AAZ, MZA, EZA, DZA, BRZ, BZA, and IND, which showed KIs 
in the range of 0.59 – 12.1 nM (Table XIII); (v) Most of the sulfonamides used 
were effective inhibitors of VchCAγ but the KIs was always ≥ 69 nM; (v) The 
inhibition profile of VchCA, VchCAβ or VchCAγ was different from that of the 
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other bacterial or mammalian CAs investigated up until now, proving that 
probably it will be possible to design VchCA-,VchCAβ- or VchCAγ-selective 
inhibitors using the scaffold of leads detected here. 
5.6.2 Anions 
In addition to sulfonamides and bioisosteres, another class of CA inhibitors 
is represented by anions. In the table XIII is shown the inhibition profile of 
VchCA, VchCAβ and VchCAγ with a series of simple and complex inorganic 
anions in comparison with those obtained for the human isoforms (hCA I and 
II) and the bacterial enzyme of Helicobacter pylori (hpαCA). 
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Table XIII. Anions inhibition constants for the human α-CAs isoforms I and II, α-CA of 
H. pylori and the three classes of CA identified in the genome of V. cholerae, obtained with the 
technique of "stopped- flow "at 20 ° C and pH 7.5. 
KIa (mM) 
Inhibitor hCA I hCA II hpαCA VchCA VchβCA VchγCA 
F- >300 >300 4,08 0,80 8,7 21,3 
Cl- 6 200 2,70 0,93 8,1 8,8 
Br- 4 63 2,41 28,0 7,4 8,7 
I- 0,3 26 6,05 9,73 9,0 6,3 
CNO- 0,0007 0,03 0,60 0,075 7,1 2,6 
SCN- 0,2 1,60 4,10 0,82 9,5 13,1 
CN- 0,0005 0,02 0,76 0,033 5,7 8,4 
N3- 0,0012 1,51 0,83 0,76 20,5 8,7 
HCO3- 12 85 0,75 5,13 5,9 3,0 
CO32- 15 73 0,66 4,64 6,7 8,2 
NO3- 7 35 0,81 0,67 8,4 7,8 
NO2- 8,4 63 0,93 34,1 9,1 8,7 
HS- 0,0006 0,04 0,69 0,074 21,3 7,9 
HSO3- 18 89 0,99 0,068 >200 >200 
SnO32- 0,57 0,83 0,55 5,32 3,1 2,9 
SeO42- 118 112 0,72 60,8 3,4 9,1 
TeO42- 0,66 0,92 0,34 14,5 2,3 7,2 
P2O74- 25,8 48,5 0,66 2,96 15,1 7,3 
V2O74- 0,54 0,57 0,27 0,84 7,9 8,3 
B4O72- 0,64 0,95 0,56 16,6 3,4 7,2 
ReO4- 0,11 0,75 0,88 5,11 6,3 >200 
RuO4- 0,101 0,69 0,36 0,61 8,4 >200 
S2O82- 0,107 0,084 0,92 84,1 3,4 >200 
SeCN 0,0085 0,086 0,73 0,76 5,3 8,7 
CS32- 0,0087 0,0088 0,38 0,088 7,0 8,8 
Et2NCS2- 0,79 3,1 0,005 0,043 0,73 0,44 
SO42- 63 >200 0,82 0,85 >200 9,6 
ClO4- >200 >200 10,1 >200 >200 >200 
BF4- >200 >200 >200 >200 >200 >200 
FSO3- 0,79 0,46 0,91 86,1 8,9 7,5 
NH(SO3)22- 0,31 0,76 0,54 88,2 >200 8,1 
H2NSO2NH2 0,31 1,13 0,073 0,008 0,054 0,084 
H2NSO3H 0,021 0,39 0,080 0,031 0,086 0,087 
PhB(OH)2 58,6 23,1 0,097 0,007 0,085 0,081 
PhAsO3H2 31,7 49,2 0,44 0,023 0,079 0,091 
  a error in the range of 3 - 5% for the reported values 
Interestingly, the carbonate and bicarbonate are not very effective inhibitors 
for V. cholerae CA (KI = 3 to 8.2 mM). This result is in agreement with the fact 
that V. cholerae colonizes the upper part of the small intestine characterized by 
high concentrations of bicarbonate, in turn considered a potent inducer of the 
expression of the genes involved in the virulence of the pathogen. This is an 
example of evolutionary adaptation of the Vibrio CAs to the high 
concentrations of bicarbonate. Interesting, also for two human isoforms (hCA I 
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and hCAII) carbonate and bicarbonate are not effective inhibitors (KI = 12-85 
mM). In fact, these anions are present in the plasma at high concentrations. 
5.7 Plasmodium falciparum 
In 2004, in genome of the protozoan Plasmodium falciparum, the causative 
agent of malaria Krungkrai and coworkers identified a gene encoding for a CA. 
This gene was identified in the GeneBank with the following accession number 
AAN35994.2. The open reading frame of the malarial CA enzyme (P. 
falciparum CA, accession number AAN35994.2, PlasmoDB: PF3D7_1140000) 
encodes a 600 amino acid polypeptide chain. In 2004, Krungkrai and coworkers 
cloned a truncated form of Plasmodium falciparum CA gene (GenBank: 
AAN35994.2) encoding for an active CA (named PfCA1) with a primary 
structure of 235 amino acid residues (Reungprapavut S., et al. 2004). The 
metalloenzyme showed a good esterase activity with 4-nitrophenylacetate as a 
substrate and was inhibited by known sulfonamide CA inhibitors (CAIs). The 
authors observed that the highly conserved α-CA active site residues, 
responsible for binding of the substrate and for catalysis, were present also in 
PfCA1 and considered thus the Plasmodium enzyme belonging to the α-CA 
class. Subsequent, it was showed that different Plasmodium spp. encoded CAs, 
all considered to belong to the α-class, and that primary sulfonamides inhibited 
in vitro and in vivo the growth of Plasmodium parasites. Recently, in the 
laboratory where I did my PhD, it was reanalyzed and realigned the amino acid 
sequence of the truncated PfCA1with the two human α-CA isoforms, hCA I and 
II, in order to identify other features of the protozoan enzyme (Figure 9). We 
observed that to have three histidines aligned with the three zinc-coordinating 
histidines of the human isoforms, it was necessary to ‘‘force’’ the alignment, 
introducing in the PfCA1 sequence a five-residues insertion and a six-residues 
deletion between residues 96–119. Nevertheless, the other residues crucial for 
the catalytic mechanism of the a-CAs, such as the proton shuttle His64 and one 
of the gatekeeper residues, Thr199, seemed to be not conserved in the 
Plasmodium enzyme (Del Prete S. et al. 2014; Vullo D. et al. 2015; Supuran 
C.T. & Capasso C. 2014) (Figure 9). The dyad Glu106-Thr199 is highly 
conserved in all a-CAs investigated so far, being involved in the orientation of 
the substrate for the nucleophilic attack by the zinc hydroxide species of the 
enzyme. Thus, the proposed alignment showed important amino acid 
substitutions that differentiated the sequence of Plasmodium enzyme from those 
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of other α-CAs. Hence, a phylogenetic tree was constructed to better investigate 
the relationship of the Plasmodia amino acid sequences with CAs from 
prokaryotic and eukaryotic species belonging to different classes (α-, β-, γ-, δ-, 
and ζ-CAs). In Figure 35 has been represented only the branches with α-, δ-, η 
and ζ-CAs). It was observed that Plasmodia CAs clustered in a branch different 
from that of the a-CAs, although close to it, while they were well separated 
from the other CA classes (Figure 35). We hypothesized that the Plasmodia 
CAs were the result of modifications of an ancestral δ-CA gene, which 
originated a new class of CA that we denominated η-class. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Phylogenetic tree that led to the discovery of η class in the genus Plasmodium, 
built using the amino acid sequences of the α-, β-, γ-, δ-, ζ- and η-CA of prokaryotic and 
eukaryotic organisms. To build the tree was used PhyML 3.0 program. 
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In collaboration with Dr. Giuseppina De Simone, we constructed, for 
homology modeling, the three-dimensional structure model of P. falciparum 
CA, aligning the entire shape of the CA of the protozoan (600 aa) with different 
amino acid sequences of α-CA with known crystallographic structure (De 
Simone G., et al. 2015) such as Neisseria gonorrhoeae, Thermovibrio 
ammonificans, Homo sapiens, Chlamydomonas reinhardtii, Aspergillus oryzae 
and Dunaliella salina. In figure 36 it is shown a detail of the structural model of 
P. falciparum CA catalytic site. 
 
 
 
 
 
 
 
 
Figure 36. Parcticular of CA catalytic site of Plasmodium falciparum modeled on the 
three-dimensional structure of known CAs. 
From that model, it shows that the metal is coordinated with two His 
residues (corresponding to residues 94 and 96 in the sequence of hCA I) and a 
residue of glutamine (which corresponds to residue His119 in sequence hCA I) 
(Figure 36). This coordination pattern was never observed in any of the CAs 
gene family. It is probable that the event, which triggered the separation of η- 
from α -class, has been the mutation of one of the histidine residues that 
coordinate the zinc ion with the residue of glutamine. Moreover, the separation 
of the class η- from the α-class, is also characterized by the replacement of the 
His residue in position 64 with a tyrosine residue (De Simone, G. et al, 2015).  
In collaboration with Prof. Claudiu Supuran, were determined the kinetic 
constants of this new class of CA. PfCA1, showed the following kinetic 
74 
 
properties for the CO2 hydration reaction to bicarbonate and protons: kcat of 1.4 
× 105s-1 and a kcat / KM of 5.4 × 10
6 M-1 × s- 1. In Table XIV were compared the 
kinetic constants of PfCA1 with those of other classes of CAs from different 
organisms. It can be noted as PfCA1 presents a significant catalytic action with 
a kcat of value in the same order of magnitude of hCA I and of the CA from 
Flaveria bidentis, while it is about 28 times less efficient than the hCA II. 
Moreover, the activity of PfCA1 is effectively inhibited by acetazolamide (KI = 
170nM). Although the η- and α-CAs share many similar features, strongly 
suggesting the first ones to be evolutionary derived from the last, there are 
significant differences between the two families to allow some optimism for the 
drug design of selective inhibitors for the parasite over the host enzymes. 
However, these studies are still in their initial phase and further work by X-ray 
crystallography should validate the model proposed in order to detect inhibitors 
with high affinity and selectivity for the η-CAs over the α-CAs 
Table XIV. Kinetic parameters for the hydration reaction of CO2 catalyzed by different 
CA belonging to different families. α class : hCA I and II and the bacterial enzyme SazCA 
(Sulfurihydrogenibium azorense). β class :  CH2 (Criptococcus neoformans) and FbiCA1 
(Flaveria bidentis). γ class : is represented by PgiCA (Porphyromonas gingivalis) and that of η 
class from PfCA1 of Plasmodim falciparum. 
 Class Organism kcat  (s-1) kcat/KM (M-1 
s-1) 
KI (nM) 
(acetazolamide) 
hCA I α Mammal 2,0 × 105 5,0 × 107 250  
hCA II α Mammal 1,4 × 106 1,5 × 108 12  
SazCA α Bacteria 4,4 × 106 3,5 × 108 0,9  
Can2 β Fungi 3,9 × 105 4,3 × 107 10,5 
FbiCA1 β Plant 1,2 × 105 7,5 × 106 27  
PgiCA γ Bacteria 4,1 × 105 5,4 × 107 324  
PfCA1 η Protozoan 1,4 × 105 5,4 × 106 170  
 
5.7.1 -CA inhibition studies 
I started to investigate the inhibition profile of the -CA from Plasmodium 
falciparum against a panel of sulfonamides and one sulfamate compound, some 
of which are clinically used. The strongest inhibitors identified were 
ethoxzolamide and sulthiame, with KIs of 131–132 nM, followed by 
acetazolamide, methazolamide and hydrochlorothiazide (KIs of 153–198 nM). 
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Brinzolamide, topiramate, zonisamide, indisulam, valdecoxib and celecoxib 
also showed significant inhibitory action against -CA, with KIs ranging from 
217 to 308 nM. Considering the small number of inhibition studies reported at 
this moment for the η-CAs, these results demonstrate it is quite probable that 
effective, low nanomolar inhibitors may be developed. Moreover, some 
dendrimers investigated showed a better inhibitory power compared to 
acetazolamide. The main conclusion is that this class of molecules may lead to 
important developments in the field of anti-infective CA inhibitors. Given that 
drug resistance has emerged against most antimalarial in clinical use, the 
discovery of η-CA -specific inhibitors may lead to a novel therapeutic approach 
for malaria once the biology of η-CA has been further investigated in different 
life cycle stages. 
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Chapter 6. Evolutionary aspects 
The analysis of the Gram-positive and Gram-negative genomes conducted 
by similarity sequence searching programs, such as Blasta and Fasta, revealed a 
very complex distribution of the different classes of CAs in the two groups of 
bacteria. In fact, the genome of some of them encodes for all three classes of 
CAs (α, β and γ), while for others the genome encodes for two or one classes of 
CAs. Interestingly, the α-CAs class are only present in the genome of Gram-
negative and not in that of Gram-positive bacteria. By analyzing these results, 
in this thesis we will try to answer the following questions: 1) Why the α-CA 
are present only in Gram-negative? 2) What is the physiological role of α-CA in 
bacteria? 3) Why the α-CAs are not present in all Gram-negative? 4) Why there 
are species of bacteria whose genome does not code for CA? 
A characteristic common to the α-CA identified in Gram-negative bacteria, 
it is the presence of a signal peptide to the N-terminal of the amino acid 
sequence (Figure 37 marked in red). This sequence directs the newly 
synthesized α-CA towards the periplasmic space, i.e. the space between the 
inner and outer membrane, which is absent in Gram-positive bacteria. The 
presence, then, of the periplasmic space would explain why the α-CA are 
present only in Gram-negative bacteria. 
 
 
 
 
Figure 37. A detail of the multialignment of the α-CA amino acid sequences identified in 
the genome of mammalian and Gram-negative bacteria. The signal sequence included in the red 
rectangle is absent in the two human isoforms hCA I and II, while it is present in the 
mitochondrial form (hCA VA) for localization in the intermembrane space, in the hCA VI for 
secretion in saliva, and in the α- CA for bacterial localization in the periplasmic space.  
To understand the role played by α-CA in Gram-negative, need to refer to 
some bacteria characterized by the presence of periplasmic α-CA. Helicobacter 
pylori is a pathogenic bacterium, Gram-negative, flagellated acidophilus, whose 
natural habitat is the gastric mucus of the human stomach. Its genome encodes 
for a α-, a β- and a γ-CA (Nishimori I., et al. 2008; Morishita S., et al. 2008; 
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Chirica L.C., et al. 2002). The α-CA has a periplasmic location, the β-CA has a 
cytoplasmic localization while still nothing is known about the expression and 
localization of γ-CA. H. pylori has developed unique adaptive mechanisms for 
growth in highly acidic environments such as the stomach. These mechanisms 
involve urease and CAs. In acidic conditions, urea penetrates into the cell 
through the channel and urea, in bacterial cytoplasm is hydrolyzed to CO2 and 
2NH3 (Supuran C.T. 2008) (Figure 38). In the bacterial cytoplasm, the CO2 is 
hydrated by β-CA, while the CO2 diffuses into the periplasm is converted to 
HCO3
- by periplasmic α-CA. The ions H+ products are used by NH3 to form 
NH4
+ in the periplasm and cytoplasm, respectively. Then, as shown in figure 
38, the role of periplasmic α-CA and cytoplasmic β-CA it is to produce HCO3- 
and protons to neutralize the acid input. In H. pylori, then, the periplasmic α-
CA is crucial for the acid acclimatization of the pathogen within the stomach. 
(Marcus E.A., et al. 2005; Sachs G., et al. 2005). 
 
 
 
 
 
 
 
 
Figure 38. Schematization of the role of the α- and β-CA in maintaining periplasmic pH in 
Helicobacter pylori. 
A similar mechanism has been reported for the Gram-negative bacterium 
Ralstonia eutropha (Gai C.S., et al. 2014). The genome of this bacterium 
encode for an α-, a β- and γ-CA. The α-CA has a periplasmic localization and 
assists the transport of bicarbonate across the cell membrane (Gai C.S., et al. 
2014). Concerning the bacterium Vibrio cholerae, the α-CA, probably located 
in the periplasmic space, could be involved in the production of bicarbonate, an 
inducer of gene expression of the virulence of the pathogen. In addition, the two 
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bacteria belonging to the genus Sulfurihydrogenibium, S. yellowstonense and S. 
azorense, which live at temperatures up to 110 ° C, exhibit α-CA characterized 
by a signal peptide for periplasmic localization of this enzyme. These 
observations allow assuming that in the course of evolution, in Gram-negative 
bacteria, a signal peptide place at the ‘N-terminal of a primordial CA, has 
generated a new class of CAs, namely the class α, with localization in the 
periplasmic compartment. Dr. Clemente Capasso and Prof. Claudiu Supuran, 
have speculated that the α-CA are able to convert the CO2 to bicarbonate 
diffused in the periplasmic space, ensuring the survival and/or satisfying the 
metabolic needs of the microorganism. Instead, the β- and γ-CA localized in the 
cytoplasm are responsible for the supply of CO2 to the carboxylase or for the 
homeostasis of intracellular pH and other functions (Capasso C. & Supuran 
C.T. 2014). 
Not all Gram-negative bacteria, however, have α-CAs. Probably the α-CAs 
are not required when the Gram-negative bacteria colonize habitats defined as 
adverse to their survival or limiting for their metabolic needs (Capasso C. & 
Supran C.T. 2014). 
There are also bacteria whose genome does not code for any class of CAs. 
A very interesting study has shown that knockout mutants for the CAs of 
Ralstonia eutropha, Escherichia coli and Saccharomyces cerevisiae are able to 
grow only in the presence of atmosphere with a CO2 level of between 2 and 5% 
(Ueda K., et al. 2012). High levels of CO2, in fact, generate high concentrations 
of bicarbonate spontaneously, through the reaction not catalyzed. These 
microorganisms lacking the CAs, at low concentrations of CO2 (0.035%) are 
not able to grow, if not by providing a sufficient amount of bicarbonate. This 
shows that the CAs are not necessary for microbial growth in environments 
with high concentrations of CO2 as the intestine, the sea water and in conditions 
of syntrophism and commensalism, but become necessary when this gas is 
present in low concentrations. The bacteria belonging to the genera Buchnera 
and Rickettsia, living in habitats with high concentration of CO2, such as soil, 
seawater or the intestine, do not need CAs. 
We also wondered if there was a relationship between the evolutionary 
history of bacterial CAs and evolution of Gram-positive and Gram-negative 
bacteria. The phylogenetic tree (Figure 39) obtained by aligning the amino acid 
sequences of the α-, β- and γ-CA identified in the genome of Gram-positive and 
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negative bacteria, showing that the γ-CA by Gram-positive and negative are 
closely associated to each other, as meaning that they form mixed groups of γ-
CA from Gram-positive and Gram-negative bacteria. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 39. Phylogenetic analysis of α-, β and γ-CA of Gram-positive and negative. For the 
construction of the dendrogram it was used the program PhyML 3.0. 
The β-CAs, unlike the γ-CAs, with the exception of LxiCAbeta_ + and 
PgiCAbeta_-, form two separate clusters, one containing the β-CAs only from 
Gram-negative bacteria and the other containing β-CAs only from Gram-
negative bacteria positive. This could be the result of a gene duplication event. 
The α-CAs, found only in Gram-negative bacteria, form a separate cluster, 
located in the same cluster of β-CAs of Gram-negative bacteria (Capasso C. & 
Supuran C.T. 2014). 
The results that come from the phylogenetic analysis is that the ancestral 
CAs are represented by the γ-class. In fact, even if the γ-class is widely 
distributed in all three domains, it is the only mainly identified in archaea, the 
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oldest living organisms on our planet (Zimmerman S., et al. 2004; Tripp B.C., 
et al. 2001 -2004; Smith K.S., et al. 1999). 
This is in agreement with the theory that supports a close relationship 
between the archaea and bacteria Gram-positive and considers phylogenetically 
distinct the Gram-negative bacteria. 
From the class γ would be originated the class β of Gram-positive and then 
that of the Gram-negative bacteria. Subsequently, from an ancestral β-CA of a 
Gram-negative bacterium, they would originate the α-CAs, the latter 
exclusively present in Gram-negative bacteria. This hypothesis can also be 
corroborated by the theory of “enzyme promiscuity" (Baas B.J., et al. 2013; 
Chakraborty S., et al. 2013; Khersonsky O., et al. 2010), i.e. the ability of an 
enzyme to catalyze additional reactions to the primary role. Tawfick considers, 
in fact, promiscuity a key factor in the evolution of a new function of the same 
protein (Khersonsky O. & Tawfik D.S. 2010). In fact, it has been noted that the 
γ-CAs use only the CO2 as substrate, while the β-CAs can hydrolyze in addition 
to CO2, also hydrogen sulfide and carbonyl sulfide. Instead, the αCA not only 
catalyze the reaction of hydration of CO2 and carbon disulphide, but also 
possess esterase and thioesterasic activity. Furthermore, by analyzing the size of 
the catalytic site bacterial of α-, β- and γ- CAs, it has been seen that the 
catalytic pocket is rather small for the γ-CAs, a bit bigger for β-CAs and wide 
for α-CAs (Figure 40). 
 
 
 
 
  
Figure 40. Three-dimensional structure of the catalytic site of the γ-(Cam), β-(Can2) and 
α-(hCA II)-CAs. 
Overall, the catalytic efficiency of γ-CA is lower than the β-CA, which in 
turn represent the catalysts less efficient than α-CA (Capasso C. & Supuran 
C.T. 2014). We can conclude that phylogenetic analysis and theory of enzyme 
γ-CA               β-CA            α-CA 
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promiscuity support the hypothesis that the most recent CA is that of class α 
(with additional catalytic activities), while the γ-CA is the class ancestral, that 
catalyzes only the reaction of hydration of CO2 (with a catalytic efficiency 
rather low). These results are in agreement with the evolutionary theory 
according to which the Gram-positive bacteria, characterized by a simple 
cellular structure, have appeared before the Gram-negative bacteria with a more 
complex cell structure (outer membrane and inner membrane). 
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Chapter 7. Discussion 
7.1 Biotechnological application 
Since CAs are very valid catalysts of the conversion of CO2 to bicarbonate, 
such enzymes may lead to the capture/sequestration of CO2 from combustion 
gases, and alleviate the global warming effects through a reduction of CO2 
emissions in the atmosphere. The interest of the study for the CAs from 
thermophilic microorganisms comes from the following consideration: the 
enzymes from thermophiles, compared to mesophilic counterpart, are 
characterized by high stability at high temperature and are resistant to the 
common denaturing agents. These features allowed their use in industrial 
processes characterized by extreme operating conditions, such as high 
temperature, high pH, high concentrations of salts etc. For this purpose, CAs 
present in the genome of extremophilic bacteria started to be investigated in 
detail ultimately. We have identified a α-CAs in the genome of the 
extremophilic bacteria Sulfurihydrogenibium yellowstonense YO3AOP1 living 
in the Yellowstone National Park, and Sulfurihydrogenibium azorense, living in 
the Azores Islands (Nakagawa S. 2005; Aguiar P. 2004). The two CAs, named 
SspCA and SazCA, were extensively investigated. Two issues related to CO2 
capture process were examined: the CO2 hydration kinetics and long-term 
stability at high temperature. The first documented carbonic anhydrase from a 
thermophile was purified from the thermophilic methanoarcheon M. 
thermoautotrophicum, but the enzyme was thermostable at temperatures up to 
75 °C and belonged to the β-CA (Smith K.S, & Ferry J.G. 1999; Smith K.S. & 
Ferry J.G. 2000). Our results showed that SspCA was stable for 3 hr. at 100 °C, 
whereas the bovine enzyme (bCA) was fully inactivated after 60 °C. Instead, 
SazCA was less thermostable than SspCA, but it had a turnover number (kcat) 
higher than that of the human enzyme (hCAII) considered the most active CA 
to date. The analysis of the amino acid sequences and the crystallographic 
structures of the two CAs explained their main features, such as the higher 
activity and thermal stability. The present thesis demonstrated that SspCA 
resulted the most stable CA never investigated, while SazCA was the faster CA 
investigated up to now.  
SspCA was efficiently immobilized within PU foam and on paramagnetic 
particles (MP) as biocatalyst to be used in the CO2 capture process. SspCA 
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covalently bound to polyurethane showed the following characteristics: a) 
preserved its activity; b) enhanced its stability for long time (60 days); c) 
resulted an efficient enzyme in the biomimetic capture of CO2. It has been 
shown, in fact, that the immobilized PU-SspCA is capable of converting about 
15% of CO2 from a gas mixture whose initial concentration was 20%. 
7.2 Biomedical application 
Infectious diseases are still today the second leading cause of death 
worldwide, and the abuse and/or inappropriate use of antibiotics have led to a 
wide spread of the phenomenon of the antibiotic resistance of pathogenic 
microorganisms (Sacarlal J., et al. 2009; Nour N.M. 2012). As a general rule 
antibiotics inhibit the growth of the pathogen by acting on metabolic 
"pathways" such as cell wall biosynthesis, biosynthesis of proteins, biosynthesis 
of DNA and RNA, biosynthesis of folates (Gaynor M. & Mankin A.S. 2003). In 
recent years, many research groups have focused their interest of study on CAs 
of bacteria, fungi and protozoa, since they constitute a class of enzymes whose 
inhibition, as reported in literature, can slow or stop the growth of the pathogen 
through a different mechanism of action respect to those reported for 
antibiotics. CAs are target molecules of many antibacterial or antifungal drugs. 
It has been proved, in fact, that the CA are essential to the life cycle of the 
microorganisms (Capasso C. & Supuran C.T. 2013; Rusconi S., et al. 2004; 
Supuran C.T. 2012). In many pathogenic microorganisms have been identified 
and characterized CAs from at least four gene families α, β, γ and η. Usually 
bacteria encode for CA belonging to the classes α, β and γ. It has been reported 
in literature that the in vivo inhibition with sulfonamides and phenolic 
derivatives of the bacterial CAs identified in Helicobacter pylori, 
Mycobacterium tuberculosis and Brucella suis, hindered the growth of 
microorganisms. The acetazolamide and ethoxzolamide have been used in the 
clinic in the 80th and 90th as anti-ulcer agents and has been shown that the 
inhibition of CA from Helicobacter pylori represented a valid alternative for the 
control of the disease. The crystallographic structure of Helicobacter pylori α-
CA complexed to acetazolamide or methazolamide represents a useful template 
for designing highly selective inhibitors for the bacterial CAs with few side 
effects. Fungi express α- and β-CA and it was found that the inhibition of these 
enzymes with sulfonamides, thiols and dithiocarbamates, block the in vivo 
growth of Malassezia globosa, Candida albicans and Crytpococcus 
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neoformans. Protozoa, however, encode for α- β- or η-CA. It has been shown 
that sulphonamidic inhibitors, thiols and idroxamates actually cause the death 
of some microorganisms in vivo such as Trypanosoma cruzi, Leishmania 
donovani chagasi and Plasmodium falciparum. In the present thesis it has been 
shown that the sulfonamides and their relative bioisosteres and, anions inhibited 
in vitro, the three classes of CAs identified in the genome of Vibrio cholerae.   
The inhibition study with a panel of sulfonamides and one sulfamate led to the 
detection of a large number of nanomolar VchCAγ inhibitors, including simple 
aromatic/heterocyclic sulfonamides (compounds 2-9, 11, 13-15, 24) as well as 
EZA, DZA, BRZ, BZA, TPM, ZNS, SLP, IND (KIS in the range of 66.2-95.3 
nM). As it was proven that bicarbonate is a virulence factor of this bacterium 
and since ethoxzolamide was shown to inhibit this virulence in vivo, we 
propose that VchCA, VchCAβ and VchCAγ may be a target for antibiotic 
development, exploiting a mechanism of action rarely considered up until now, 
i.e., interference with bicarbonate supply as a virulence factor. The inhibition 
profile of VchCA, VchCAβ or VchCAγ was different from that of the other 
bacterial or mammalian CAs investigated up until now, proving that probably it 
will be possible to design VchCA, VchCAβ or VchCAγ selective inhibitors 
using the scaffold of leads detected here. 
For the treatment of diseases such as malaria, for example, several drugs 
are available, but over the years, their effectiveness is greatly diminished and, 
thus, remains the problem of antibiotic resistance. Protozoa, such as 
Plasmodium falciparum, utilize purines and pyrimidines for DNA/RNA 
synthesis during its exponential growth and replication. Plasmodia synthesize 
pyrimidines de novo from HCO3
-, which is the substrate of the first enzyme 
involved in the Plasmodia pyrimidine pathway. HCO3
- is generated from CO2 
through the action of a CA. Our studies have shown that PfCA1, the CA 
identified in the genome of Plasmodium falciparum, belongs to a new class of 
CAs, called η. The metal ion coordination pattern of the -CA from the malaria 
producing protozoa P. falciparum is unique among all six genetic families 
encoding for such enzymes, comprising two His and one Gln residues, in 
addition to the water molecule/hydroxide ion acting as nucleophile in the 
catalytic cycle. To date, few inhibitors were tested for η-CA. The attempt to 
selectively inhibit the CA of pathogenic organisms such as bacteria, protozoa 
and fungi, can represent an alternative approach for the design of 
antibacterial/pesticides/antifungal with a novel mechanism of action. α-CAs are 
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potential drug targets, as shown by the use of sulfonamides in the clinic for the 
treatment of infection by Helicobacter pylori (Puscas I. 1984) and for the β-, γ- 
or η-class CAs there is a great interest in identifying selective inhibitors, since 
they are absent in humans and other mammals.  
7.3 Phylogenetic analysis 
The complex distribution of the various CA classes in Gram-positive and 
negative bacteria allowed us to find a correlation between the evolutionary 
history of the bacteria and the three CA classes (α, β and γ) identified in their 
genome. Prokaryotes appeared on the Earth 3.5-3.8 billion years ago, while 
eukaryotes were dated 1.8 billion years ago. During the first 2.0-2.5 billion 
years the Earth's atmosphere not contained oxygen, thus the first organisms 
were anaerobic. Eukaryotic organisms almost aerobes developed on the Earth 
when the atmosphere was characterized by stable and relatively high oxygen 
content. All the oldest part of the evolutionary history of the planet and more 
than 90% of the phylogenetic diversity of life can be attributed to the microbial 
world. Moreover, the fact that the archaea are distinct from other prokaryotes is 
demonstrated by the existence of protein sequences that are present in archaea, 
but not in eubacteria (Gupta R.S. 1998). Many phylogenetic methods support a 
close correlation of archaea with Gram-positive bacteria, while Gram-negative 
bacteria form a separate clade, indicating their phylogenetic distinction. Gupta 
et al. believe that the Gram-positive bacteria occupy an intermediate position 
between archaea and Gram-negative bacteria, and that they evolved precisely 
from archaea. Phylogenetic analysis of carbonic anhydrases identified in 
bacteria Gram-positive and negative, showed that the ancestral CA is 
represented by γ-class. In, fact, the γ-CA is the only CA class, which has been 
identified in archaea (Zimmerman S., et al. 2004; Tripp B.C., et al. 2001-2004; 
Smith K.S., et al. 1999). This is consistent with the theory that maintains a 
close relationship between the archaea and the Gram-positive bacteria, 
considering Gram-negative arising from the latter. Furthermore, phylogenetic 
analysis of bacterial CAs showed that the α-CAs, exclusively present in Gram-
negative bacteria, were the most recent CAs. These results have been 
corroborated by the enzymatic promiscuity theory, which is the ability of an 
enzyme to catalyze a side reaction in addition to main reaction (Torrance J.W., 
et al. 2007). In fact, as described in the Results section, the α-CAs can catalyze 
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secondary reaction, such as the hydrolysis of p-NpA or thioester, in addition to 
its primary reaction consisting in the CO2 hydration.  
7.4 Conclusions 
My PhD project brought new insights in the field of carbonic anhydrases. It 
has been demonstrated: a) the thermostable and thermoactive CAs identified in 
thermophilic bacteria are good candidates in the CO2 capture process; b) the 
studies carried out on the CAs from pathogens have identified selective 
inhibitors to be used as anti-infective; c) the discovery of the η-CA, a new 
genetic families of CAs; d) the introduction of a new technique, named 
protonography, useful for the identification of CA activity on a polyacrylamide 
gel; and to the phylogenetic analysis of the α-, β- and γ-CAs identified in the 
genome of the Gram-positive and Gram-negative bacteria. 
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Supuran C.T. Synthesis and Carbonic Anhydrase Isoenzymes I, II, IX, 
and XII Inhibitory Effects of Dimethoxybromophenol Derivatives 
Incorporating Cyclopropane Moieties. Journal of medicinal chemistry, 
2015; 58(2):640-50. 
Briganti, F., Mangani, S., Orioli, P., Scozzafava, A., Vernaglione, G., Supuran 
C.T., Carbonic anhydrase activators: X-ray crystallographic and 
spectroscopic investigations for the interaction of isozymes I and II with 
histamine. Biochemistry, 1997; 36, 10384-10392.  
Brodelius, P. and Mosbach, K. (1987) Immobilization Techniques for 
Cells/Organelles. In: Methods in Enzymology, volume 135, (Mosbach, 
K., ed.), Academic Press, London, pp. 173–454. 
Buchholz, K. and Klein, J. (1987) Characterization of Immobilized 
Biocatalysts. In: Methods in Enzymology volume 135, (Mosbach, K., 
ed.), Academic Press, London, pp. 3–30. 
Capasso C., De Luca V., Carginale V., Cannio R., Rossi M. Biochemical 
properties of a novel and highly thermostable bacterial ’-carbonic 
anhydrase from Sulfurihydrogenibium yellowstonense YO3AOP1. J 
Enzyme Inhib Med Chem 2012; 27:892–897 
Capasso C., Supuran C.T. An overview of the alpha-, beta- and gamma-
carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases 
89 
 
shed new light on evolution of bacteria? J Enzyme Inhib Med Chem. 
2014; 30(2):325-32. 
Capasso C., Supuran C.T. Anti-infective carbonic anhydrase inhibitors: a patent 
and literature review. Expert Opin Ther Pat. 2013; 23(6):693-704.  
Capasso C., Supuran C.T. Bacterial Carbonic Anhydrases as Drug Targets. The 
Carbonic Anhydrases as Biocatalyst 2015; 271-281. 
Cardoso T., Ribeiro O., Aragao I.C., et al. Additional risk factors for infection 
by multidrug-resistant pathogens in healthcare-associated infection: a 
large cohort study. BioMed Central Infectious Disease 2012; 12:375. 
Cash R.A., Music S.I., Libonati J.P., Snyder M.J., Wenzel R.P., Hornick R.B. 
Response of man to infection with Vibrio cholerae. I. Clinical, serologic, 
and bacteriologic responses to a known inoculum. J Infect Dis. 
1974;129(1):45-52.  
Cash R.A., Music S.I., Libonati J.P., Snyder M.J., Wenzel R.P., Hornick R.B. 
Response of man to infection with Vibrio cholerae. I. Clinical, serologic, 
and bacteriologic responses to a known inoculum. J. Infect. Dis. 1974; 
129, 45−52.  
Chakraborty S., Minda R., Salaye L., Dandekar A.M., Bhattacharjee S.K., Rao 
B.J. Promiscuity-based enzyme selection for rational directed evolution 
experiments. Methods Mol Biol. 2013; 978:205-16. 
Chegwidden W.R., Carter N.D., Edwards Y.H. The Carbonic Anhydrases: New 
Horizons, 2000; 12-28.  
Chirica L.C., Elleby B., Jonsson B.H., Lindskog S. The complete sequence, 
expression in Escherichia coli, purification and some properties of 
carbonic anhydrase from Neisseria gonorrhoeae. Eur J Biochem. 1997; 
244(3):755-60. 
Chirica L.C., Petersson C., Hurtig M., Jonsson B.H., Borén T., Lindskog S. 
Expression and localization of alpha- and beta-carbonic anhydrase in 
Helicobacter pylori. Biochim Biophys Acta. 2002; 1601(2):192-9. 
Clare B.W. and Supuran C.T. Carbonic anhydrase activators. 3: structure-
activity correlations for a series of isozyme II activators. J Pharm Sci. 
1994; 83(6):768-73. 
90 
 
Cox G.M., McDade H.C., Chen S.C., Tucker SC, Gottfredsson M, Wright LC, 
Sorrell TC, Leidich SD, Casadevall A, Ghannoum MA et al. Extracellular 
phospholipase activity is a virulence factor for Cryptococcus neoformans. 
Molecular Microbiology 2001; 39:166-75. 
Cox G.M., Mukherjee .J, Cole G.T., et al. Urease as a virulence factor in 
experimental cryptococcosis. Infection and Immunity 2000; 68:443-487.  
Cronk J.D., Endrizzi J.A., Cronk M.R., O’Neill J.W., Zhang K.Y.J. Crystal 
structure of E. coli beta-carbonic anhydrase, an enzyme with an unusual 
pH-dependent activity. Protein Sci 2001; 10: 911-922. 
De Luca V., Del Prete S., Supuran C.T., Capasso C. Protonography, a new 
technique for the analysis of carbonic anhydrase activity. J Enzyme Inhib 
Med Chem. 2015; 30(2):277-82. 
De Simone G., Di Fiore A., Capasso C., Supuran C.T. The zinc coordination 
pattern in the η-carbonic anhydrase from Plasmodium falciparum is 
different from all other carbonic anhydrase genetic families. Bioorg Med 
Chem Lett. 2015; 25(7):1385-9.  
De Simone G., Supuran C.T. (In)organic anions as carbonic anhydrase 
inhibitors. J Inorg Biochem. 2012; 111:117-29.  
De Simone, G., Di Fiore, A., Supuran C.T., Are carbonic anydrase inhibitors 
suitable for obtaining antiobesity drugs. Current Pharmaceutical 
Design 2008; 14, 655–660. 
Del Prete S., De Luca V., Scozzafava A., Carginale V., Supuran C.T., Capasso 
C. Biochemical properties of a new alpha-carbonic anhydrase from the 
human pathogenic bacterium, Vibrio cholerae . J Enzyme Inhib Med 
Chem 2014; 29 : 23 – 7. 
Del Prete S., De Luca V., Vullo D., Scozzafava A., Carginale V., Supuran C.T., 
Capasso C. Biochemical characterization of the γ-carbonic anhydrase 
from the oral pathogen Porphyromonas gingivalis, PgiCA. J Enzyme 
Inhib Med Chem. 2014; 29(4):532-7.  
Del Prete S., Isik S., Vullo D., De Luca V., Carginale V., Scozzafava A., 
Supuran C.T., Capasso C. DNA cloning, characterization, and inhibition 
studies of an α-carbonic anhydrase from the pathogenic bacterium Vibrio 
cholerae. J Med Chem. 2012; 55(23):10742-8.  
91 
 
Del Prete S., Vullo D., De Luca V., AlOthman Z., Osman S.M., Supuran C.T., 
Capasso C. Biochemical characterization of recombinant β-carbonic 
anhydrase (PgiCAb) identified in the genome of the oral pathogenic 
bacterium Porphyromonas gingivalis. J Enzyme Inhib Med Chem. 2014; 
1-5. 
Del Prete S., Vullo D., De Luca V., Supuran C.T., Capasso C. Biochemical 
characterization of the δ-carbonic anhydrase from the marine diatom 
Thalassiosira weissflogii, TweCA. J Enzyme Inhib Med Chem. 2014; 
29(6):906-11. 
Del Prete S., Vullo D., Fisher G.M., Andrews K.T., Poulsen S.A., Capasso C., 
Supuran CT. Discovery of a new family of carbonic anhydrases in the 
malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases. 
Bioorg Med Chem Lett. 2014 ; 24(18):4389-96. 
Di Fiore A., Alterio V., Monti S.M., De Simone G., D'Ambrosio K. 
Thermostable Carbonic Anhydrases in Biotechnological Applications. Int 
J Mol Sci. 2015;  8;16(7):15456-80. doi: 10.3390/ijms160715456. 
Di Fiore A., Capasso C., De Luca V., Monti S.M., Carginale V., Supuran C.T., 
Scozzafava A., Pedone C., Rossi M., De Simone G. X-Ray structure of 
the first “extremo-’-carbonic anhydrase”, a dimeric enzyme from the 
thermophilic bacterium, Sulfurihydrogenibium yellostonense YO3AOP1. 
Acta Crystallographica Section D: Biological Crystallography, 2013; 
69.6: 1150-1159. 
DiCosimo R., McAuliffe J., J. Poulose A. and Bohlmann G. Industrial use of 
immobilized enzymes Chem. Soc. Rev., 2013; 42, 6437 
Dlugokencky E. Annual Mean Carbon Dioxide Data. Earth System Research 
Laboratory. National Oceanic & Atmospheric Administration. Retrieved 
12 February 2016 
Dogne, J. M., Hanson, J., Supuran, C.T., Pratico, D. Coxibs and cardiovascular 
side-effects: from light to shadow. Curr Pharm Des 2006; 12, 8, 971-975. 
Domsic J. F., Avvaru B. S., Kim C.U., Gruner S.M., Agbandje-McKenna M., 
Silverman, D.N., McKenna R., Entrapment of carbon dioxide in the 
active site of carbonic anhydrase II. J. Biol. Chem., 2008; 283, 30766-
30771. 
92 
 
Dudutienė V., Matulienė J., Smirnov A., Timm D.D., Zubrienė A., 
Baranauskienė L., Morkūnaite V., Smirnovienė J., Michailovienė V., 
Juozapaitienė V., Mickevičiūtė A., Kazokaitė J., Bakšytė S., 
Kasiliauskaitė A., Jachno J., Revuckienė J., Kišonaitė M., Pilipuitytė V., 
Ivanauskaitė E., Milinavičiūtė G., Smirnovas V., Petrikaitė V., Kairys V., 
Petrauskas V., Norvaišas P., Lingė D., Gibieža P., Capkauskaitė E., 
Zakšauskas A., Kazlauskas E., Manakova E., Gražulis S., Ladbury J.E., 
Matulis D. Discovery and characterization of novel selective inhibitors of 
carbonic anhydrase IX. J Med Chem. 2014; 57(22):9435-46. 
Edsall J.T. Multiple molecular forms of carbonic anhydrase in erythrocytes. 
Ann N Y Acad Sci. 1968; 151(1):41-63. 
Falkowski P., Scholes R.J., Boyle E., Canadell J., Canfield D., Elser J., Gruber 
N., Hibbard K., Högberg P., Linder S., MacKenzie F.T., et al The Global 
Carbon Cycle: A Test of Our Knowledge of Earth as a System. Science  
2000; 290 (5490): 291–296 
Forsman C., Behravan G., Osterman A., Jonsson B.H. Production of active 
human carbonic anhydrase II in E. coli. Acta Chem Scand 1988; 42:314–
318. 
Gaynor M., Mankin A.S. Macrolide antibiotics: binding site, mechanism of 
action, resistance. Curr Top Med Chem 2003; 3:949-61. 
Grosso-Becera M.V., Servín-González L., Soberón-Chávez G. RNA structures 
are involved in the thermoregulation of bacterial virulence-associated 
traits. Trends Microbiol. 2015; pii: S0966-842X(15)00098-0. doi: 
10.1016/j.tim.2015.04.004. 
Gupta R.S. What are archaebacteria: life's third domain or monoderm 
prokaryotes related to gram-positive bacteria? A new proposal for the 
classification of prokaryotic organisms. Mol Microbiol. 1998; 29(3):695-
707. Review. 
Harris J.B., LaRocque R.C., Qadri F., Ryan E..T, Calderwood S.B. Cholera. 
Lancet. 2012; 379(9835):2466-76.  
Huesemann M.H., Hausmann T.S., Bartha R., Aksoy M., Weissman J.C., 
Benemann J.R. Biomass productivities in wild type and pigment mutant 
of Cyclotella sp. (Diatom). Appl Biochem Biotechnol 2009; 157:507–
526. 
93 
 
Innocenti A., Zimmerman S., Casini A., Ferry J.G., Scozzafava A., Supuran 
C.T. Carbonic anhydrase inhibitors. Inhibition of the zinc and cobalt 
gamma-class enzyme from the archaeon Methanosarcina thermophila 
with anions Bioorg Med Chem Lett 2004; 14: 3327- 31. 
James P., Isupov M.N.,  Sayer C.,  Saneei  V.,  Berg  S.,  Lioliou  M.,  Kotlar  
H.K.,  Littlechild J.A. The structure of a tetrameric alpha-carbonic 
anhydrase from Thermovibrio ammonificans reveals a core formed 
around intermolecular disulfides that contribute to its thermostability. 
Acta Crystallogr. D Biol. Crystallogr. 2014; 70, 2607–2618. 
Joseph P, Ouahrani-Bettache S, Montero JL, Nishimori I, Minakuchi T, Vullo 
D, Scozzafava A, Winum JY, Kohler S, Supuran CT. 2011. A new beta-
carbonic anhydrase from Brucella suis, its cloning, characterization, and 
inhibition with sulfonamides and sulfamates, leading to impaired 
pathogen growth. Bioorg Med Chem 19: 1172-1178. 
Joyce S.A., Watson R.J., Clarke D.J. The regulation of pathogenicity and 
mutualism in Photorhabdus. Current Opinion in 
Microbiology  2006;9:127-132. 
Kanbar B., Ozdemir E. Thermal stability of carbonic anhydrase immobilized 
within polyurethane foam. Biotechnol Prog 2010;26: 1474–1480. 
Khalifah R.G. The carbon dioxide hydration activity of carbonic anhydrase. I. 
Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol 
Chem. 1971; 246(8):2561-73. 
Khersonsky O., Tawfik D.S. Enzyme promiscuity: a mechanistic and 
evolutionary perspective. Annu Rev Biochem. 2010; 79:471-505. 
Kimber M.S., Pai E.F. The active site architecture of Pisum sativum β-carbonic 
anhydrase is a mirror image of that of α-carbonic anhydrases. EMBO J 
2000; 19: 2323-2330. 
Knudsen J.F., Carlsson U., Hammarstrom P., Sokol G.H., Cantilena L.R. The 
cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human 
carbonic anhydrasem II. Inflammation 2004; 28, 5, 285-290. 
Köhler K. et al. Saccharin inhibits carbonic anhydrases: possible explanation 
for its unpleasant metallic aftertaste. Angewandte Chemie International 
Edition 46; 2007; 7697–7699.  
94 
 
Krebs H. A. Inhibition of carbonic anhydrase by sulphonamides. Biochem J 
1948; 43, 4, 525-528. 
Krissinel E. and Henrick K. Inference of macromolecular assemblies from 
crystalline state. J. Mol. Biol. 2007; 372, 774–797. 
Krungkrai J., Supuran C.T. The alpha-carbonic anhydrase from the malaria 
parasite and its inhibition. Curr Pharm Des. 2008; 14(7):631-40. 
Krungkrai SR, Suraveratum N, Rochanakij S, Krungkrai J. 2001. 
Characterisation of carbonic anhydrase in Plasmodium falciparum. Int J 
Parasitol 31: 661-668. 
Lee R. B.Y., Smith  J A.C., Rickaby  R.E.M.J. Phycol. 2013; 49, 170. 
Maeda S., Price G.D., Badger M.R., Enomoto C., Omata T.. Bicarbonate 
binding activity of the CmpA protein of the cyanobacterium 
Synechococcus sp. strain PCC 7942 involved in active transport of 
bicarbonate. J Biol Chem. 2000; 275(27):20551-5.  
Mandal S., Mandal M.D., Pal N.K. Cholera: a great global concern. Asian Pac. 
J. Trop. Med. 2011; 4, 573−580. 
Marcus E.A., Moshfegh A.P., Sachs G., Scott D.R. The periplasmic alpha-
carbonic anhydrase activity of Helicobacter pylori is essential for acid 
acclimation. J Bacteriol. 2005; 187(2):729-38. 
Meldrum N.U., Roughton F.J. Carbonic anhydrase. Its preparation and 
properties. J Physiol. 1933; 80(2):113-42. 
Menlove K.J., Clement M., Crandall K.A. Similarity searching using BLAST. 
Methods Mol Biol 2009; 537:1–22. 
Mincione F., Scozzafava A. and Supuran C.T. (2009). Antiglaucoma carbonic 
anhydrase inhibitors as ophthalomologic drugs (pp. 139-154). Wiley: 
Hoboken (NJ). 
Mitsuhashi S, Mizushima T., Yamashita E., Yamamoto M., Kumasaka T., 
Moriyama H., et al. X-ray structure of .beta-carbonic anhydrase from the 
red alga, Porphyridium purpureum, reveals a novel catalytic site for CO2 
hydration. J Biol Chem 2000; 275: 5521-6. 
Morishita S., Nishimori I., Minakuchi T., et al. Cloning, polymorphism, and 
inhibition of beta-carbonic anhydrase of Helicobacter pylori. J 
Gastroenterol 2008; 43:849–57. 
95 
 
Nishimori I., Minakuchi T., Kohsaki T., Onishi S., Takeuchi H., Vullo D., et al. 
Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from 
Helicobacter pylori is a new target for sulfonamide and sulfamate 
inhibitors. Bioorg Med Chem Lett 2007; 17: 3585-94. 
Nishimori I., Minakuchi T., Morimoto K., Sano S., Onishi S., Takeuchi H., et 
al. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of 
the alpha-carbonic anhydrase from Helicobacter pylori, a new target for 
developing sulfonamide and sulfamate gastric drugs . J Med Chem 2006; 
49 : 2117 – 26. 
Nishimori I., Onishi S., Takeuchi H., Supuran C.T. The alpha and beta classes 
carbonic anhydrases from Helicobacter pylori as novel drug targets. Curr 
Pharm Des 2008; 14:622–30. 
Nishimori I., Onishi S., Vullo D., Innocenti A., Scozzafava A., Supuran C.T. 
Carbonic anhydrase activators: the first activation study of the human 
secretory isoform VI with amino acids and amines. Bioorg. Med. Chem. 
Lett. 2007; 17, 5351–5357. 
Nour N.M. Premature delivery and the millennium development goal. Rev 
Obstet Gynecol 2012; 5:100-5. 
Pearson W.R. Using the FASTA program to search protein and DNA sequence 
databases. Methods Mol Biol. 1994; 24:307-31.  
Pouwels J., Moracci M., Cobucci-Ponzano B., Perugino G., van der Oost J., 
Kaper T. et al. Activity and stability of hyperthermophilic enzymes: A 
comparative study on two archaeal β-glycosidases. Extremophiles 
2000;4:157–164. 
Puscas I. Treatment of gastroduodenal ulcers with carbonic anhydrase 
inhibitors. Ann NY Acad Sci 1984; 429:587–91. 
Reichle D., et al. Carbon sequestration research and development, 1999 Rep. 
DOE/SC/FE-1, U.S. Dep. of Energy, Washington, D. C. 
Reungprapavut S., Krungkrai S.R., Krungkrai J. Plasmodium falciparum 
carbonic anhydrase is a possible target for malaria chemotherapy. J 
Enzyme Inhib Med Chem. 2004; 19(3):249-56. 
Revelle R. & MunkW. Chapter: 10. The Carbon Dioxide Cycle and the 
Biosphere. Energy and Climate: Studies in Geophysics 1977 
96 
 
Rossi M. (1995). Proteins and enzymes from extremophiles: Academical and 
industrial prospects. New York: Plenum Press. 
Roux O., Cereghino R., Solano P.J., et al. Caterpillars and fungal pathogens: 
two co-occurring parasites of an ant-plant mutualism. PLoS One 2011; 
6:e20538. 
Rusconi S., Scozzafava A., Mastrolorenzo A., et al. New advances in HIV entry 
inhibitors development. Curr Drug Targets Infect Disord 2004; 4:339-55. 
Sacarlal J., Nhacolo A.Q., Sigauque B., et al. A 10 year study of the cause of 
death in children under 15 years in Manhica, Mozambique. BMC Public 
Health 2009; 9:67. 
Sachs G., Weeks D.L., Wen Y., Marcus E.A., Scott D.R., Melchers K. Acid 
acclimation by Helicobacter pylori. Physiology (Bethesda). 2005; 20:429-
38. Review. 
Sainsbury P.D., Mineyeva Y., Mycroft Z., Bugg T.D.H. Chemical intervention 
in bacterial lignin degradation pathways: Development of selective 
inhibitors for intradiol and extradiol catechol dioxygenases. Bioorg 
Chem. 2015; 60:102-9.  
Schaller M., Borelli C., Korting H.C., et al. Hydrolytic enzymes as virulence 
factors of Candida albicans. Mycoses 2005; 48:365-377. 
Scozzafava A., Briganti F., Ilies M.A. & Supuran C.T. Carbonic anhydrase 
inhibitors. Synthesis of membrane-impermeant low molecular weight 
sulfonamides possessing in vivo selectivity for the membrane-bound 
versus the cytosolic isozymes. Journal of Medicinal Chemistry. 2000; 43, 
292–300. 
Sein K.K., Aikawa M. 1998. The pivotal role of carbonic anhydrase in malaria 
infection. Med Hypotheses 50: 19-23. 
Smith K.S., Ferry J.G. A plant-type (β-class) carbonic anhydrase in the 
thermophilic methanoarchaeon Methanobacterium thermoautotrophicum. 
J Bacteriol 1999; 181: 6247-53. 
Smith K.S., Ferry J.G. Prokaryotic carbonic anhydrases. FEMS Microbiol Rev 
2000; 24: 335-66. 
97 
 
Smith K.S., Jakubzick C., Whittam T.S., Ferry J.G. Carbonic anhydrase is an 
ancient enzyme widespread in prokaryotes. Proc Natl Acad Sci U S A. 
1999; 96(26):15184-9. 
Soto W., Punke E.B., Nishiguchi M.K. Evolutionary perspectives in a 
mutualism of sepiolid squid and bioluminescent bacteria: combined usage 
of microbial experimental evolution and temporal population genetics. 
Evolution 2012; 66:1308-1321. 
Stams T., Christianson D.W. X-ray crystallographic studies of mammalian 
carbonic anhydrase isozymes. In The Carbonic Anhydrases—New 
Horizons; Chegwidden, W. R., Edwards, Y., Carter, N., Eds.; Birkhäuser 
Verlag, Basel, 2000; 159–174. 
Strop P., Smith K.S., Iverson T.M., Ferry J.G., Rees D.C. Crystal structure of 
the "cab"-type beta class carbonic anhydrase from the archaeon 
Methanobacterium thermoautotrophicum. J Biol Chem 2001; 276: 10299-
305. 
Sun M.K. and Alkon D.L. Carbonic anhydrase gating of attention: memory 
therapy and enhancement. Trends Pharmacol. Sci. 2002; 23, 83–89. 
Sun M.K. and Alkon D.L. Pharmacological enhancement of synaptic efficacy, 
spatial learning, and memory through carbonic anhydrase activation in 
rats. J. Pharmacol. Exp. Ther. 2001; 297, 961–967. 
Supuran C.T. and Winum J.Y. In Drug Design of Zinc-Enzyme Inhibitors: 
Functional, Structural, and Disease Applications. Ophthalomologic 
Drugs. 2009; 139–154.  
Supuran C.T. Bacterial carbonic anhydrases as drug targets: toward novel 
antibiotics? Front Pharmacol. 2011; 2:34 
Supuran C.T. Carbonic anhydrase inhibition/activation: trip of a scientist 
around the world in the search of novel chemotypes and drug targets. Curr 
Pharm Des 2010; 16 : 3233 – 45. 
Supuran C.T. Carbonic anhydrase inhibitors and activators for novel therapeutic 
applications. Future Med Chem. 2011; 3(9):1165-80. Review. 
Supuran C.T. Carbonic Anhydrases – An Overview Current Pharmaceutical 
Design. Bentham Science Publishers Ltd, 2008; 14,603-614.  
98 
 
Supuran C.T. Carbonic anhydrases: novel therapeutic applications for inhibitors 
and activators. Nat Rev Drug Discovery 2008; 7:168 – 81. 
Supuran C.T. Inhibition of bacterial carbonic anhydrases and zinc proteases: 
from orphan targets to innovative new antibiotic drugs. Curr Med Chem 
2012; 19:831-44. 
Supuran C.T., Capasso C. The eta-class carbonic anhydrases as drug targets for 
antimalarial agents. Expert Opin Ther Targets 2014; 1-13. 
Supuran C.T., De Simone G. Carbonic Anhydrase: An Overview. The Carbonic 
Anhydrases as Biocatalyst 2015; 3-11. 
Supuran C.T., Di Fiore A., Alterio V., Monti S.M., De Simone G. Recent 
advances in structural studies of the carbonic anhydrase family: the 
crystal structure of human CA IX and CA XIII. Curr Pharm Des. 2010; 
16(29):3246-54. 
Supuran C.T., Diuretics: from classical carbonic anhydrase inhibitors to novel 
applications of the sulfonamides. Current Pharmaceutical Design 
2008; 14, 641-648.  
Supuran C.T., Scozzafava A., Conway J. (Eds.): Carbonic anhydrase- Its 
inhibitors and activators, CRC Press, Boca Raton (FL), USA, 2004; 1-
363. 
Supuran C.T., Scozzafava A., Ilies M.A. and Briganti F. Carbonic anhydrase 
inhibitors. Synthesis of sulfonamides incorporating 
2,4,6-trisubstituted-pyridinium-ethylcarboxamido moieties possessing 
membrane-impermeability and in vivo selectivity for the membrane-
bound (CA IV) versus the cytosolic (CA I and CA II) isozymes. Journal 
of Enzyme Inhibition and Medicinal Chemistry.2000; 15, 381–401. 
Supuran CT. 2008. Carbonic anhydrases: novel therapeutic applications for 
inhibitors and activators. Nat Rev Drug Discov 7: 168-181. 
Supuran, C.T, Ilies M.A. and Scozzafava A. Carbonic anhydrase inhibitors. Part 
29. Interaction of isozymes I, II and IV with benzolamide-like derivatives. 
European Journal of Medicinal Chemistry. 1998; 33, 739–752.  
Supuran, C.T., Di Fiore A., De Simone G. Carbonic anhydrase inhibitors as 
emerging drugs for the treatment of obesity. Expert Opinion on 
Emerging Drugs 2008; 13, 383-392.  
99 
 
Supuran, C.T., Scozzafava A., Conway J., Eds.; Carbonic Anhydrase. Its 
Inhibitors and Activators; CRC Press: Boca Raton (FL), USA, 2004; 1–
363. 
Tanc M., Carta F., Scozzafava A., Supuran C.T. α-Carbonic Anhydrases 
Possess Thioesterase Activity. ACS Med Chem Lett. 2015; 6(3):292-5. 
Temperini C., Innocenti A., Scozzafava A., Mastrolorenzo A., Supuran C.T. 
Carbonic anhydrase activators: LAdrenaline plugs the active site entrance 
of isozyme II, activating better isoforms I, IV, VA, VII, and XIV. Bioorg. 
Med. Chem. Lett., 2007; 17, 628-635. 
Temperini C., Innocenti A., Scozzafava A., Supuran C.T., Carbonic anhydrase 
activators: kinetic and X-.ray crystallographic study for the interaction of 
D- and L-tryptophan with the mammalian isoforms I-XIV. Bioorg. Med. 
Chem., 2008; 16, 8373-8378. 
Temperini C., Scozzafava A., Puccetti L., Supuran C.T., Carbonic anhydrase 
activators: X-ray crystal structure of the adduct of human isozyme II with 
L-histidine as a platform for the design of stronger activators. Bioorg. 
Med. Chem. Lett., 2005; 15, 5136-5141. 
Temperini C., Scozzafava A., Supuran C.T. Carbonic anhydrase activators: the 
first X-ray crystallographic study of an adduct of isoform I. Bioorg. Med. 
Chem. Lett. 2006; 16, 5152–5156. 
Temperini C., Scozzafava A., Vullo D., Supuran C.T. Carbonic anhydrase 
activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and 
d-histidine and crystallographic analysis of their adducts with isoform II: 
engineering proton-transfer processes within the active site of an enzyme. 
Chemistry, 2006; 12, 7057-7066. 
Tibayrenc M., Ayala F.J. Reproductive clonality of pathogens: A perspective on 
pathogenic viruses, bacteria, fungi, and parasitic protozoa. Proc Natl Acad 
Sci USA 2012. 109: E3305-3313. 
Trevan M. Techniques of Immobilization. In: Immobilized Enzymes. An 
Introduction and Applications in Biotechnology (Trevan, M., ed.), 1980 
Wiley, Chichester-New York, pp. 1–9. 
Tripp B.C., Bell C.B. 3rd, Cruz F., Krebs C., Ferry J.G. A role for iron in an 
ancient carbonic anhydrase. J Biol Chem. 2004; 279(8):6683-7.  
100 
 
Tripp B.C., Smith K., Ferry J.G. Carbonic anhydrase: new insights for an 
ancient enzyme. J Biol Chem. 2001; 276(52):48615-8. 
Ueda K., Nishida H., Beppu T. Dispensabilities of carbonic anhydrase in 
proteobacteria. Int J Evol Biol 2012; 2012:324549 (1–5). 
Viparelli F., Monti S.M., De Simone G., Innocenti A., Scozzafava A., Xu Y., 
Morel F.M., Supuran C.T. Inhibition of the R1 fragment of the cadmium-
containing zeta-class carbonic anhydrase from the diatom Thalassiosira 
weissflogii with anions. Bioorg Med Chem Lett. 2010; 20(16):4745-8. 
Vullo D., Del Prete S., Fisher G.M., Andrews K.T., Poulsen S.A., Capasso C., 
Supuran C.T. Sulfonamide inhibition studies of the η-class carbonic 
anhydrase from the malaria pathogen Plasmodium falciparum. Bioorg 
Med Chem. 2015; 23(3):526-31.  
Vullo D., Del Prete S., Osman S.M., Scozzafava A., Alothman Z., Supuran 
C.T., Capasso C. Anion inhibition study of the β-class carbonic anhydrase 
(PgiCAb) from the oral pathogen Porphyromonas gingivalis. Bioorg Med 
Chem Lett. 2014; 24(18):4402-6. 
Vullo D., Isik S., Del Prete S., De Luca V., Carginale V., Scozzafava A., 
Supuran C.T., Capasso C. Anion inhibition studies of the α-carbonic 
anhydrase from the pathogenic bacterium Vibrio cholera. Bioorg Med 
Chem Lett. 2013; 23(6):1636-8..  
Wang M., Lawal A., Stephenson P., Sidders J. and Ramshaw C. Post-
combustion CO 2 capture with chemical absorption: a state-of-the-art 
review. Chemical Engineering Research and Design, 2011; 89(9), 1609-
1624. 
Wassmer S.C., Taylor T.E., Rathod P.K., Mishra S.K., Mohanty S., Arevalo-
Herrera M., Duraisingh M.T., Smith J.D. Investigating the Pathogenesis 
of Severe Malaria: A Multidisciplinary and Cross-Geographical 
Approach. Am J Trop Med Hyg. 2015 Aug 10. pii: 14-0841. 
Webb S.A.R. and Kahler C.M. Bench-to-bedside review: Bacterial virulence 
and subversion of host defences. BioMed Central Ltd 2008; 12:234.  
Winum J.Y., Ram, M., Scozzafava A., Montero J.L., Supuran C.T. Carbonic 
anhydrase IX: a new druggable target for the design of antitumor agents. 
Med. Res. Rev., 2008; 28, 445-463. 
101 
 
Winum J.Y., Temperini C., El Cheikh K., Innocenti A., Vullo D., Ciattini S., 
Montero J.L., Scozzafava A., Supuran C.T. Carbonic anhydrase 
inhibitors: clash with Ala65 as a means for designing inhibitors with low 
affinity for the ubiquitous isozyme II, exemplified by the crystal structure 
of the topiramate sulfamide analogue. J. Med. Chem. 2006; 49, 7024–
7031. 
Xu Y., Feng L., Jeffrey P.D., Shi Y., Morel F.M. Structure and metal exchange 
in the cadmium carbonic anhydrase of marine diatoms. Nature. 2008; 
452(7183):56-61. 
Yang H., Xu Z., Fan M., Gupta R., Slimane R.B., Bland A.E. and Wright I. 
Progress in carbon dioxide separation and capture: A review. Journal of 
Environmental Sciences, 2008; 20(1), 14-27. 
Yu C.H., Huang C.H., Tan C.S. A review of CO2 capture by absorption and 
adsorption. Aerosol and Air Quality Research, 2012; 12.5: 745-769. 
Zimmerman S., Innocenti A., Casini A., Ferry J.G., Scozzafava A., Supuran 
C.T.Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and 
gamma-class enzymes from Archaea with sulfonamides. Bioorg Med 
Chem Lett. 2004; 14(24):6001-6. 
 
